UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)


Delaware						01-0666114
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	HURN	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting
Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of ~~July 22,~~October 26, 2021, ~~22,445,893~~21,917,598 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Table of Contents


Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


		June 30, 2021		December 31, 2020			September 30, 2021		December 31, 2020
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	12,982	$	67,177	Cash and cash equivalents	$	11,189	$	67,177
Receivables from clients, net of allowances of $8,809 and $7,680, respectively		116,091		87,687
Unbilled services, net of allowances of $3,214 and $2,603, respectively		90,119		53,959
Receivables from clients, net of allowances of $8,236 and $7,680, respectively						Receivables from clients, net of allowances of $8,236 and $7,680, respectively	111,548		87,687
Unbilled services, net of allowances of $2,738 and $2,603, respectively						Unbilled services, net of allowances of $2,738 and $2,603, respectively	94,862		53,959
Income tax receivable	Income tax receivable	1,811		5,121		Income tax receivable	2,120		5,121
Prepaid expenses and other current assets	Prepaid expenses and other current assets	14,642		16,569		Prepaid expenses and other current assets	13,624		16,569
Total current assets	Total current assets	235,645		230,513		Total current assets	233,343		230,513
Property and equipment, net	Property and equipment, net	31,271		29,093		Property and equipment, net	30,654		29,093
Deferred income taxes, net	Deferred income taxes, net	4,745		4,191		Deferred income taxes, net	1,726		4,191
Long-term investments	Long-term investments	66,639		71,030		Long-term investments	68,216		71,030
Operating lease right-of-use assets	Operating lease right-of-use assets	36,575		39,360		Operating lease right-of-use assets	37,367		39,360
Other non-current assets	Other non-current assets	64,488		62,068		Other non-current assets	64,463		62,068
Intangible assets, net	Intangible assets, net	18,957		20,483		Intangible assets, net	16,663		20,483
Goodwill	Goodwill	597,552		594,237		Goodwill	597,552		594,237
Total assets	Total assets	$	1,055,872	$	1,050,975	Total assets	$	1,049,984	$	1,050,975
Liabilities and stockholders’ equity	Liabilities and stockholders’ equity					Liabilities and stockholders’ equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	6,318	$	648	Accounts payable	$	5,918	$	648
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	19,822		14,874		Accrued expenses and other current liabilities	18,520		14,874
Accrued payroll and related benefits	Accrued payroll and related benefits	90,158		133,830		Accrued payroll and related benefits	103,526		133,830

Current maturities of long-term debt	Current maturities of long-term debt	551		499		Current maturities of long-term debt	555		499
Current maturities of operating lease liabilities	Current maturities of operating lease liabilities	9,598		8,771		Current maturities of operating lease liabilities	10,066		8,771
Deferred revenues	Deferred revenues	19,182		28,247		Deferred revenues	17,820		28,247
Total current liabilities	Total current liabilities	145,629		186,869		Total current liabilities	156,405		186,869
Non-current liabilities:	Non-current liabilities:					Non-current liabilities:
Deferred compensation and other liabilities	Deferred compensation and other liabilities	46,843		47,131		Deferred compensation and other liabilities	40,582		47,131

Long-term debt, net of current portion	Long-term debt, net of current portion	267,502		202,780		Long-term debt, net of current portion	262,362		202,780
Operating lease liabilities, net of current portion	Operating lease liabilities, net of current portion	57,324		61,825		Operating lease liabilities, net of current portion	56,873		61,825
Deferred income taxes, net	Deferred income taxes, net	436		428		Deferred income taxes, net	394		428
Total non-current liabilities	Total non-current liabilities	372,105		312,164		Total non-current liabilities	360,211		312,164
Commitments and contingencies	Commitments and contingencies	0		0		Commitments and contingencies	0		0
Stockholders’ equity	Stockholders’ equity					Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 24,877,563 and 25,346,916 shares issued at June 30, 2021 and December 31, 2020, respectively		243		246
Treasury stock, at cost, 2,445,818 and 2,584,119 shares at June 30, 2021 and December 31, 2020, respectively		(135,364)		(129,886)
Common stock; $0.01 par value; 500,000,000 shares authorized; 24,377,457 and 25,346,916 shares issued, respectively						Common stock; $0.01 par value; 500,000,000 shares authorized; 24,377,457 and 25,346,916 shares issued, respectively	238		246
Treasury stock, at cost, 2,457,456 and 2,584,119 shares, respectively						Treasury stock, at cost, 2,457,456 and 2,584,119 shares, respectively	(135,903)		(129,886)
Additional paid-in capital	Additional paid-in capital	429,084		454,512		Additional paid-in capital	409,910		454,512
Retained earnings	Retained earnings	232,211		214,009		Retained earnings	245,938		214,009
Accumulated other comprehensive income	Accumulated other comprehensive income	11,964		13,061		Accumulated other comprehensive income	13,185		13,061
Total stockholders’ equity	Total stockholders’ equity	538,138		551,942		Total stockholders’ equity	533,368		551,942
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	1,055,872	$	1,050,975	Total liabilities and stockholders’ equity	$	1,049,984	$	1,050,975

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited)


		Three Months Ended June 30,				Six Months Ended June 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020			2021		2020		2021		2020
Revenues and reimbursable expenses:	Revenues and reimbursable expenses:									Revenues and reimbursable expenses:
Revenues	Revenues	$	230,126	$	217,857	$	433,339	$	440,476	Revenues	$	224,007	$	205,304	$	657,346	$	645,780
Reimbursable expenses	Reimbursable expenses	3,252		2,970		5,186		22,273		Reimbursable expenses	3,690		2,860		8,876		25,133
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	233,378		220,827		438,525		462,749		Total revenues and reimbursable expenses	227,697		208,164		666,222		670,913
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):	Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):									Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
Direct costs	Direct costs	161,526		149,514		309,641		305,762		Direct costs	153,902		145,459		463,543		451,221
Amortization of intangible assets and software development costs	Amortization of intangible assets and software development costs	910		1,334		1,835		2,635		Amortization of intangible assets and software development costs	910		1,370		2,745		4,005
Reimbursable expenses	Reimbursable expenses	3,316		2,866		5,319		22,255		Reimbursable expenses	3,914		2,840		9,233		25,095
Total direct costs and reimbursable expenses	Total direct costs and reimbursable expenses	165,752		153,714		316,795		330,652		Total direct costs and reimbursable expenses	158,726		149,669		475,521		480,321
Operating expenses and other losses (gains), net	Operating expenses and other losses (gains), net									Operating expenses and other losses (gains), net
Selling, general and administrative expenses	Selling, general and administrative expenses	45,190		44,857		84,956		88,303		Selling, general and administrative expenses	43,520		38,561		128,476		126,864
Restructuring charges	Restructuring charges	861		109		1,489		1,718		Restructuring charges	1,677		59		3,166		1,777
Litigation and other losses (gains)	Litigation and other losses (gains)	0		0		42		(150)		Litigation and other losses (gains)	56		—		98		(150)
Depreciation and amortization	Depreciation and amortization	5,446		6,193		10,874		12,307		Depreciation and amortization	5,412		6,176		16,286		18,483
Goodwill impairment charges	Goodwill impairment charges	0		0		0		59,816		Goodwill impairment charges	—		—		—		59,816
Total operating expenses and other losses (gains), net	Total operating expenses and other losses (gains), net	51,497		51,159		97,361		161,994		Total operating expenses and other losses (gains), net	50,665		44,796		148,026		206,790
Operating income (loss)	Operating income (loss)	16,129		15,954		24,369		(29,897)		Operating income (loss)	18,306		13,699		42,675		(16,198)
Other income (expense), net:	Other income (expense), net:									Other income (expense), net:
Interest expense, net of interest income	Interest expense, net of interest income	(2,029)		(2,916)		(3,748)		(5,257)		Interest expense, net of interest income	(2,217)		(2,259)		(5,965)		(7,516)
Other income (expense), net	Other income (expense), net	2,151		3,948		2,571		(1,348)		Other income (expense), net	(394)		2,035		2,177		687
Total other income (expense), net		122		1,032		(1,177)		(6,605)
Total other expense, net										Total other expense, net	(2,611)		(224)		(3,788)		(6,829)
Income (loss) from continuing operations before taxes	Income (loss) from continuing operations before taxes	16,251		16,986		23,192		(36,502)		Income (loss) from continuing operations before taxes	15,695		13,475		38,887		(23,027)
Income tax expense (benefit)	Income tax expense (benefit)	3,454		3,414		4,990		(7,801)		Income tax expense (benefit)	1,968		2,388		6,958		(5,413)
Net income (loss) from continuing operations	Net income (loss) from continuing operations	12,797		13,572		18,202		(28,701)		Net income (loss) from continuing operations	13,727		11,087		31,929		(17,614)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		(25)		0		(60)		Loss from discontinued operations, net of tax	—		(29)		—		(89)
Net income (loss)	Net income (loss)	$	12,797	$	13,547	$	18,202	$	(28,761)	Net income (loss)	$	13,727	$	11,058	$	31,929	$	(17,703)
Net earnings (loss) per basic share:	Net earnings (loss) per basic share:									Net earnings (loss) per basic share:
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	0.59	$	0.62	$	0.84	$	(1.31)	Net income (loss) from continuing operations	$	0.65	$	0.50	$	1.48	$	(0.81)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		0		0		(0.01)		Loss from discontinued operations, net of tax	—		—		—		—
Net income (loss)	Net income (loss)	$	0.59	$	0.62	$	0.84	$	(1.32)	Net income (loss)	$	0.65	$	0.50	$	1.48	$	(0.81)
Net earnings (loss) per diluted share:	Net earnings (loss) per diluted share:									Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	0.59	$	0.61	$	0.82	$	(1.31)	Net income (loss) from continuing operations	$	0.64	$	0.50	$	1.46	$	(0.81)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		0		0		(0.01)		Loss from discontinued operations, net of tax	—		—		—		—
Net income (loss)	Net income (loss)	$	0.59	$	0.61	$	0.82	$	(1.32)	Net income (loss)	$	0.64	$	0.50	$	1.46	$	(0.81)
Weighted average shares used in calculating earnings (loss) per share:	Weighted average shares used in calculating earnings (loss) per share:									Weighted average shares used in calculating earnings (loss) per share:
Basic	Basic	21,555		21,869		21,743		21,848		Basic	21,242		21,905		21,574		21,868
Diluted	Diluted	21,871		22,116		22,105		21,848		Diluted	21,531		22,175		21,904		21,868
Comprehensive income (loss):	Comprehensive income (loss):									Comprehensive income (loss):
Net income (loss)	Net income (loss)	$	12,797	$	13,547	$	18,202	$	(28,761)	Net income (loss)	$	13,727	$	11,058	$	31,929	$	(17,703)
Foreign currency translation adjustments, net of tax	Foreign currency translation adjustments, net of tax	82		104		482		(675)		Foreign currency translation adjustments, net of tax	(246)		381		236		(294)
Unrealized gain (loss) on investment, net of tax	Unrealized gain (loss) on investment, net of tax	1,422		(5,678)		(3,226)		(5,936)		Unrealized gain (loss) on investment, net of tax	1,158		4,885		(2,068)		(1,051)
Unrealized gain (loss) on cash flow hedging instruments, net of tax	Unrealized gain (loss) on cash flow hedging instruments, net of tax	218		(1,705)		1,647		(3,390)		Unrealized gain (loss) on cash flow hedging instruments, net of tax	309		(243)		1,956		(3,633)
Other comprehensive income (loss)	Other comprehensive income (loss)	1,722		(7,279)		(1,097)		(10,001)		Other comprehensive income (loss)	1,221		5,023		124		(4,978)
Comprehensive income (loss)	Comprehensive income (loss)	$	14,519	$	6,268	$	17,105	$	(38,762)	Comprehensive income (loss)	$	14,948	$	16,081	$	32,053	$	(22,681)

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)


		Three Months Ended June 30,																					Three Months Ended September 30,
		Common Stock			Treasury Stock			Additional Paid-In Capital				Retained Earnings			Accumulated Other Comprehensive Income				Stockholders’ Equity				Common Stock						Treasury Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income			Stockholders’ Equity
		Shares	Amount		Shares	Amount								Shares								Amount			Shares			Amount
Balance at March 31, 2021		24,698,499	$	247	(2,887,999)	$	(134,611)			$	445,711						$	219,414			$	10,242		$	541,003
Balance at June 30, 2021																						Balance at June 30, 2021	24,321,728			$	243		(2,899,933)	$	(135,364)		$	429,084		$	232,211		$	11,964		$	538,138
Comprehensive income	Comprehensive income											12,797			1,722				14,519			Comprehensive income													13,727			1,221			14,948
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	21,820	0		(9,091)	(605)		605											0			Restricted stock awards, net of cancellations	45,190			—			1,371	77		(77)									—
Exercise of stock options	Exercise of stock options	6,772	—					248											248			Exercise of stock options	5,000			—						191									191
Share-based compensation	Share-based compensation							4,575											4,575			Share-based compensation										5,693									5,693
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(2,843)	(148)													(148)			Shares redeemed for employee tax withholdings							(12,489)	(616)											(616)

Share repurchases	Share repurchases	(405,363)	(4)					(22,055)											(22,059)			Share repurchases	(518,045)			(5)						(24,981)									(24,986)
Balance at June 30, 2021		24,321,728	$	243	(2,899,933)	$	(135,364)	$	429,084			$	232,211		$	11,964			$	538,138
Balance at September 30, 2021																						Balance at September 30, 2021	23,853,873			$	238		(2,911,051)	$	(135,903)	$	409,910		$	245,938		$	13,185		$	533,368

Balance at March 31, 2020		24,559,854	$	246	(2,780,835)	$	(128,366)	$	444,974			$	195,541		$	12,214			524,609
Balance at June 30, 2020																						Balance at June 30, 2020	24,586,236			$	246		(2,786,798)	$	(128,646)	$	450,391		$	209,088		$	4,935		536,014
Comprehensive income	Comprehensive income											13,547			(7,279)				6,268			Comprehensive income													11,058			5,023			16,081
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	19,582	0		(4,157)	(196)		196											0			Restricted stock awards, net of cancellations	51,860			1			(4,130)	(212)		211									—
Exercise of stock options	Exercise of stock options	6,800	—					178											178			Exercise of stock options	6,800			—						179									179
Share-based compensation	Share-based compensation							5,043											5,043			Share-based compensation										3,372									3,372
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(1,806)	(84)													(84)			Shares redeemed for employee tax withholdings							(12,468)	(580)											(580)
Balance at June 30, 2020		24,586,236	$	246	(2,786,798)	$	(128,646)	$	450,391			$	209,088		$	4,935			$	536,014
Balance at September 30, 2020																						Balance at September 30, 2020	24,644,896			$	247		(2,803,396)	$	(129,438)	$	454,153		$	220,146		$	9,958		$	555,066


		Six Months Ended June 30,																					Nine Months Ended September 30,
		Common Stock			Treasury Stock			Additional Paid-In Capital				Retained Earnings			Accumulated Other Comprehensive Income				Stockholders’ Equity				Common Stock							Treasury Stock						Additional Paid-In Capital				Retained Earnings				Accumulated Other Comprehensive Income				Stockholders’ Equity
		Shares	Amount		Shares	Amount								Shares								Amount			Shares				Amount
Balance at December 31, 2020	Balance at December 31, 2020	24,560,855	$	246	(2,812,896)	$	(129,886)			$	454,512						$	214,009			$	13,061		$	551,942	Balance at December 31, 2020		24,560,855			$	246			(2,812,896)			$	(129,886)			$	454,512			$	214,009			$	13,061	$	551,942
Comprehensive income	Comprehensive income											18,202			(1,097)				17,105			Comprehensive income																		31,929				124				32,053
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	398,551	4		81,009	3,173		(3,177)											0			Restricted stock awards, net of cancellations	443,741			4				82,380			3,250				(3,254)												—
Exercise of stock options	Exercise of stock options	13,403	—					422											422			Exercise of stock options	18,403			—										613												613
Share-based compensation	Share-based compensation							12,563											12,563			Share-based compensation														18,256												18,256
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(168,046)	(8,651)													(8,651)			Shares redeemed for employee tax withholdings								(180,535)			(9,267)															(9,267)
Share repurchases	Share repurchases	(651,081)	(7)					(35,236)											(35,243)			Share repurchases	(1,169,126)			(12)										(60,217)												(60,229)
Balance at June 30, 2021		24,321,728	$	243	(2,899,933)	$	(135,364)	$	429,084			$	232,211		$	11,964			$	538,138
Balance at September 30, 2021																						Balance at September 30, 2021	23,853,873			$	238			(2,911,051)			$	(135,903)		$	409,910			$	245,938			$	13,185			$	533,368

Balance at December 31, 2019	Balance at December 31, 2019	24,603,308	$	247	(2,763,302)	$	(128,348)	$	460,781			$	237,849		$	14,936			$	585,465		Balance at December 31, 2019	24,603,308			$	247			(2,763,302)			$	(128,348)		$	460,781			$	237,849			$	14,936			$	585,465
Comprehensive income												(28,761)			(10,001)				(38,762)
Comprehensive loss																						Comprehensive loss																		(17,703)				(4,978)				(22,681)
Issuance of common stock in connection with:	Issuance of common stock in connection with:																					Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	Restricted stock awards, net of cancellations	270,126	2		98,310	6,919		(6,921)											0			Restricted stock awards, net of cancellations	321,986			3				94,180			6,707			(6,710)												—
Exercise of stock options	Exercise of stock options	26,800	—					646											646			Exercise of stock options	33,600			—										825												825
Share-based compensation	Share-based compensation							16,763											16,763			Share-based compensation														20,135												20,135
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings				(121,806)	(7,217)													(7,217)			Shares redeemed for employee tax withholdings								(134,274)			(7,797)															(7,797)
Share repurchases	Share repurchases	(313,998)	(3)					(20,878)											(20,881)			Share repurchases	(313,998)			(3)										(20,878)												(20,881)
Balance at June 30, 2020		24,586,236	$	246	(2,786,798)	$	(128,646)	$	450,391			$	209,088		$	4,935			$	536,014
Balance at September 30, 2020																						Balance at September 30, 2020	24,644,896			$	247			(2,803,396)			$	(129,438)		$	454,153			$	220,146			$	9,958			$	555,066

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


		Six Months Ended June 30,					Nine Months Ended September 30,
		2021		2020			2021		2020
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Net income (loss)	Net income (loss)	$	18,202	$	(28,761)	Net income (loss)	$	31,929	$	(17,703)
Adjustments to reconcile net income (loss) to cash flows from operating activities:	Adjustments to reconcile net income (loss) to cash flows from operating activities:					Adjustments to reconcile net income (loss) to cash flows from operating activities:
Depreciation and amortization	Depreciation and amortization	12,923		14,942		Depreciation and amortization	19,245		22,511
Non-cash lease expense	Non-cash lease expense	3,301		3,880		Non-cash lease expense	4,912		5,844

Share-based compensation	Share-based compensation	11,566		14,527		Share-based compensation	17,979		18,559
Amortization of debt discount and issuance costs	Amortization of debt discount and issuance costs	397		397		Amortization of debt discount and issuance costs	595		595
Goodwill impairment charges	Goodwill impairment charges	0		59,816		Goodwill impairment charges	—		59,816
Allowances for doubtful accounts	Allowances for doubtful accounts	0		512		Allowances for doubtful accounts	—		539
Deferred income taxes	Deferred income taxes	(48)		(15,515)		Deferred income taxes	2,434		(16,125)
Loss on sale of business	Loss on sale of business	0		102		Loss on sale of business	—		102
Change in fair value of contingent consideration liabilities	Change in fair value of contingent consideration liabilities	42		0		Change in fair value of contingent consideration liabilities	98		—
Other, net	Other, net	(236)		0		Other, net	(325)		—
Changes in operating assets and liabilities, net of acquisition and divestiture:	Changes in operating assets and liabilities, net of acquisition and divestiture:					Changes in operating assets and liabilities, net of acquisition and divestiture:
(Increase) decrease in receivables from clients, net	(Increase) decrease in receivables from clients, net	(27,749)		(339)		(Increase) decrease in receivables from clients, net	(23,294)		23,493
(Increase) decrease in unbilled services, net	(Increase) decrease in unbilled services, net	(36,088)		(3,059)		(Increase) decrease in unbilled services, net	(40,883)		1,597
(Increase) decrease in current income tax receivable / payable, net	(Increase) decrease in current income tax receivable / payable, net	3,366		6,546		(Increase) decrease in current income tax receivable / payable, net	3,159		9,455
(Increase) decrease in other assets	(Increase) decrease in other assets	(1,117)		(1,674)		(Increase) decrease in other assets	98		(3,426)
Increase (decrease) in accounts payable and other liabilities	Increase (decrease) in accounts payable and other liabilities	5,038		(2,787)		Increase (decrease) in accounts payable and other liabilities	2,229		(5,272)
Increase (decrease) in accrued payroll and related benefits	Increase (decrease) in accrued payroll and related benefits	(42,487)		(53,420)		Increase (decrease) in accrued payroll and related benefits	(35,958)		(25,290)
Increase (decrease) in deferred revenues	Increase (decrease) in deferred revenues	(9,080)		6,638		Increase (decrease) in deferred revenues	(10,424)		3,290
Net cash provided by (used in) operating activities	Net cash provided by (used in) operating activities	(61,970)		1,805		Net cash provided by (used in) operating activities	(28,206)		77,985
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Purchases of property and equipment, net	Purchases of property and equipment, net	(5,439)		(4,417)		Purchases of property and equipment, net	(8,918)		(5,731)
Purchase of investment securities	Purchase of investment securities	0		(13,000)		Purchase of investment securities	—		(13,000)
Investment in life insurance policies	Investment in life insurance policies	(77)		(1,540)		Investment in life insurance policies	(574)		(2,026)

Purchase of business	Purchase of business	(5,886)		0		Purchase of business	(5,886)		(801)
Capitalization of internally developed software costs	Capitalization of internally developed software costs	(2,508)		(5,184)		Capitalization of internally developed software costs	(3,603)		(6,830)

Proceeds from sale of property and equipment	Proceeds from sale of property and equipment	158		0		Proceeds from sale of property and equipment	255		—

Net cash used in investing activities	Net cash used in investing activities	(13,752)		(24,141)		Net cash used in investing activities	(18,726)		(28,388)
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from exercises of stock options	Proceeds from exercises of stock options	422		646		Proceeds from exercises of stock options	613		825
Shares redeemed for employee tax withholdings	Shares redeemed for employee tax withholdings	(8,651)		(7,217)		Shares redeemed for employee tax withholdings	(9,267)		(7,797)
Share repurchases	Share repurchases	(35,243)		(22,115)		Share repurchases	(60,229)		(22,115)
Proceeds from bank borrowings	Proceeds from bank borrowings	139,000		283,000		Proceeds from bank borrowings	189,000		283,000
Repayments of bank borrowings	Repayments of bank borrowings	(74,270)		(160,263)		Repayments of bank borrowings	(129,362)		(240,396)

Net cash provided by financing activities		21,258		94,051
Net cash provided by (used in) financing activities						Net cash provided by (used in) financing activities	(9,245)		13,517
Effect of exchange rate changes on cash	Effect of exchange rate changes on cash	269		(107)		Effect of exchange rate changes on cash	189		27
Net increase (decrease) in cash and cash equivalents	Net increase (decrease) in cash and cash equivalents	(54,195)		71,608		Net increase (decrease) in cash and cash equivalents	(55,988)		63,141
Cash and cash equivalents at beginning of the period	Cash and cash equivalents at beginning of the period	67,177		11,604		Cash and cash equivalents at beginning of the period	67,177		11,604
Cash and cash equivalents at end of the period	Cash and cash equivalents at end of the period	$	12,982	$	83,212	Cash and cash equivalents at end of the period	$	11,189	$	74,745
Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:	Non-cash investing and financing activities:					Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits	Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits	$	3,315	$	2,070	Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits	$	2,140	$	2,049
Operating lease right-of-use asset obtained in exchange for operating lease liability	Operating lease right-of-use asset obtained in exchange for operating lease liability	$	0	$	1,397	Operating lease right-of-use asset obtained in exchange for operating lease liability	$	2,960	$	1,456

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, Huron creates sustainable results for the organizations it serves.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and ~~six~~nine months ended ~~June~~September 30, 2021 and 2020. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2020 included in our Annual Report on Form 10-K and our Quarterly ~~Report~~Reports on Form 10-Q for the ~~period~~periods ended March 31, 2021 and June 30, 2021. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

During the first quarter of 2021, we identified an error on our previously reported consolidated balance sheet as of December 31, 2020

related to the classification between receivables from clients, unbilled services, and deferred revenues. Our consolidated balance sheet as

of December 31, 2020 presented herein has been revised to reflect the correction of this error. The results of this correction on our

consolidated balance sheet were a decrease in unbilled services of $7.2 million, an increase in receivables from clients of $0.7 million, and a

decrease in deferred revenues of $6.5 million. This error had no impact on our consolidated statement of operations and other

comprehensive income and consolidated statements of cash flows for any current or prior period. We evaluated the materiality of this error from both quantitative and qualitative perspectives and concluded that the impact of the error was not material to the financial statements for the year ended December 31, 2020.

Preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and related disclosures. The business and economic uncertainty resulting from the coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to predict. Accordingly, actual results and outcomes could differ from those estimates.

3. New Accounting Pronouncements

Recently Adopted

In October 2020, the FASB issued ~~ASU~~Accounting Standards Update ("ASU") 2020-10, Codification Improvements. ASU 2020-10 situates all disclosure guidance within the appropriate disclosure section of the Codification and makes other improvements and technical corrections to the Codification. We adopted ASU 2020-10 effective January 1, 2021, which did not have any impact on our consolidated financial statements.

Not Yet Adopted

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01, Reference Rate Reform (Topic 848): Scope. Together, these ASUs provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting under GAAP. This standard is optional and may be applied by entities after March 12, 2020, but no later than December 31, 2022. We have certain debt instruments and related interest rate swaps that are indexed to LIBOR; as such, we are currently evaluating the potential impact this guidance will have on our consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the ~~six~~nine months ended ~~June~~September 30, 2021.

Healthcare
Business
Advisory Education Total
Balance as of December 31, 2020:
Goodwill $ 636,810 $ 308,935 $ 104,384 $ 1,050,129
Accumulated impairment losses (208,081) (247,811) 0 (455,892)
Goodwill, net as of December 31, 2020 428,729 61,124 104,384 594,237
Goodwill recorded in connection with a business acquisition (1)
0 3,315 0 3,315
Goodwill, net as of June 30, 2021 $ 428,729 $ 64,439 $ 104,384 $ 597,552


	Healthcare		Business Advisory		Education		Total
Balance as of December 31, 2020:
Goodwill	$	636,810	$	308,935	$	104,384	$	1,050,129
Accumulated impairment losses	(208,081)		(247,811)		—		(455,892)
Goodwill, net as of December 31, 2020	428,729		61,124		104,384		594,237
Goodwill recorded in connection with a business acquisition (1)	—		3,315		—		3,315


Goodwill, net as of September 30, 2021	$	428,729	$	64,439	$	104,384	$	597,552

(1)On February 1, 2021, we completed the acquisition of Unico Solution, a data strategy and technology consulting firm focused on helping clients use their data to speed business transformation and accelerate cloud adoption. The results of operations of Unico Solution are included in our consolidated financial statements and results of operations of our Business Advisory segment from the date of acquisition. This acquisition is not significant to our consolidated financial statements.

First Quarter 2020 Goodwill Impairment Charges

The worldwide spread of the COVID-19 pandemic in the first quarter of 2020 created significant volatility, uncertainty and disruption to

the global economy. From the onset of the COVID-19 pandemic, we closely monitored the impact it could have on all aspects of our

business, including how we expect it to negatively impact our clients, employees and business partners. While the COVID-19 pandemic did

not have a significant impact on our consolidated revenues in the first quarter of 2020, we expected it to have an unfavorable impact on

sales, increase uncertainty in the backlog and negatively impact full year 2020 results. The services provided by our Strategy and Innovation

and Life Sciences reporting units within our Business Advisory segment focus on strategic solutions for healthy, well-capitalized companies to

identify new growth opportunities, which may be considered by our clients to be more discretionary in nature, and the duration of the projects

within these practices are typically short-term. Therefore, at the onset of the COVID-19 pandemic in the U.S. and due to the uncertainty

caused by the pandemic, we were cautious about near-term results for these two reporting units. Based on our internal projections and the

preparation of our financial statements for the quarter ended March 31, 2020, and considering the expected decrease in demand due to the

COVID-19 pandemic, during the first quarter of 2020 we believed it was more likely than not that the fair value of these two reporting units no

longer exceeded their carrying values and performed an interim impairment test on both reporting units as of March 31, 2020.

Based on the estimated fair values of the Strategy and Innovation and Life Sciences reporting units, we recorded non-cash pretax goodwill impairment charges of $49.9 million and $9.9 million, respectively, in the first quarter of 2020. The $49.9 million non-cash pretax charge related to the Strategy and Innovation reporting unit reduced the goodwill balance of the reporting unit to $37.5 million. The $9.9 million non-cash pretax charge related to the Life Sciences reporting unit reduced the goodwill balance of the reporting unit to 0.zero.

Our goodwill impairment test was performed by comparing the fair value of each of the Strategy and Innovation and Life Sciences reporting

units with its respective carrying value and recognizing an impairment charge for the amount by which the carrying value exceeded the fair value. To estimate the fair value of each reporting unit, we relied on a combination of the income approach and the market approach with a

fifty-fifty weighting.

In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be

generated by each reporting unit and then discounting those cash flows to present value, reflecting the relevant risks associated with each

reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted

revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating

future cash flows, we relied on internally generated seven-year forecasts. Our forecasts are based on historical experience, current backlog,

expected market demand, and other industry information.

In the market approach, we utilized the guideline company method, which involved calculating revenue multiples based on operating data

from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable

investor in the marketplace would be willing to pay for a company. These multiples were evaluated and adjusted based on specific

characteristics of the Strategy and Innovation and Life Sciences reporting units relative to the selected guideline companies and applied to

the reporting units' operating data to arrive at an indication of value.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~the reporting units' operating data to arrive at an indication of value.~~

Intangible Assets

Intangible assets as of ~~June~~September 30, 2021 and December 31, 2020 consisted of the following:


			As of June 30, 2021				As of December 31, 2020						As of September 30, 2021				As of December 31, 2020
		Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	Customer relationships	3 to 13	$	71,465	$	54,833	$	73,629	$	56,232	Customer relationships	3 to 13	$	71,273	$	56,496	$	73,629	$	56,232
Trade names	Trade names	6	6,000		4,653		6,130		4,287		Trade names	6	6,000		4,901		6,130		4,287
Technology and software	Technology and software	5	5,800		5,509		5,800		5,380		Technology and software	5	5,800		5,543		5,800		5,380
Non-competition agreements	Non-competition agreements	5	1,880		1,330		2,090		1,541		Non-competition agreements	5	1,720		1,258		2,090		1,541
Customer contracts	Customer contracts	2	800		663		800		526		Customer contracts	2	800		732		800		526
Total	Total		$	85,945	$	66,988	$	88,449	$	67,966	Total		$	85,593	$	68,930	$	88,449	$	67,966

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships and customer contracts, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was ~~$2.3~~$2.2 million and $3.2 million for the three months ended ~~June~~September 30, 2021 and 2020, respectively; and ~~$4.7~~$6.9 million and ~~$6.4~~$9.6 million for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of ~~June~~September 30, 2021.


Year Ending December 31,	Year Ending December 31,	Estimated Amortization Expense		Year Ending December 31,	Estimated Amortization Expense(1)
2021	2021	$	9,059	2021	$	9,059
2022	2022	$	6,878	2022	$	6,878
2023	2023	$	4,231	2023	$	4,231
2024	2024	$	1,384	2024	$	1,384
2025	2025	$	566	2025	$	566

(1)On November 1, 2021, we completed the divestiture of the Life Sciences business, including the sale of customer relationships previously acquired which had a net book value of $2.0 million as of September 30, 2021. The amortization of these customer relationships is included in the table above through 2024.

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

5. Revenues

For the three months ended ~~June~~September 30, 2021 and 2020, we recognized revenues of ~~$230.1~~$224.0 million and ~~$217.9~~$205.3 million, respectively. Of the ~~$230.1~~$224.0 million recognized in the ~~second~~third quarter of 2021, we recognized revenues of ~~$15.7~~$4.3 million from obligations satisfied, or partially satisfied, in prior periods, of which ~~$13.5~~$2.2 million was primarily due to the release of allowances on unbilled services and $2.1 million was due to changes in the estimates of our variable consideration under performance-based billing ~~arrangements and $2.2~~arrangements. Of the $205.3 million recognized in the third quarter of 2020, we recognized revenues of $7.4 million from obligations satisfied, or partially satisfied, in prior periods, of which $5.7 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments. Of the $217.9 million recognized in the second quarter of 2020, we recognized revenues of $5.6 million from obligations satisfied, or partially satisfied, in prior periods, of which $4.0 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and ~~$1.6~~$1.7 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.

For the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, we recognized revenues of ~~$433.3~~$657.3 million and ~~$440.5~~$645.8 million, respectively. Of the ~~$433.3~~$657.3 million recognized in the first ~~six~~nine months of 2021, we recognized revenues of ~~$20.8~~$22.1 million from obligations satisfied, or partially satisfied, in prior periods, of which ~~$13.9~~$14.6 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and ~~$6.9~~$7.5 million was primarily due to the release of allowances on unbilled ~~services as a result of securing contract amendments.~~services. Of the ~~$440.5~~$645.8 million recognized in the first ~~six~~nine months of 2020, we recognized revenues of ~~$10.0~~$11.0 million from obligations satisfied, or partially satisfied, in prior periods, of which ~~$6.2~~$6.5 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and ~~$3.8~~$4.5 million was primarily due to the release of allowances on unbilled ~~services as a result of securing contract amendments.~~services.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

As of ~~June~~September 30, 2021, we had ~~$66.7~~$72.8 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the ~~$66.7~~$72.8 million of performance obligations, we expect to recognize approximately ~~$29.2~~$15.8 million as revenue in 2021, ~~$23.1~~$30.2 million in 2022, and the remaining ~~$14.4~~$26.8 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of ~~June~~September 30, 2021 and December 31, 2020 was ~~$25.8~~$20.8 million and $17.3 million, respectively. The ~~$8.5~~$3.5 million increase primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of ~~June~~September 30, 2021 and December 31, 2020, was ~~$19.2~~$17.8 million and $28.2 million, respectively. The ~~$9.0~~$10.4 million decrease primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and ~~six~~nine months ended ~~June~~September 30, 2021, ~~$5.2~~$1.3 million and ~~$26.0~~$27.3 million of revenues recognized were included in the deferred revenue balance as of December 31, 2020.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

6. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss from continuing operations, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss from continuing operations per share would be anti-dilutive.

Earnings (loss) per share under the basic and diluted computations are as follows:


		Three Months Ended June 30,				Six Months Ended June 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020			2021		2020		2021		2020
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	12,797	$	13,572	$	18,202	$	(28,701)	Net income (loss) from continuing operations	$	13,727	$	11,087	$	31,929	$	(17,614)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		(25)		0		(60)		Loss from discontinued operations, net of tax	—		(29)		—		(89)
Net income (loss)	Net income (loss)	$	12,797	$	13,547	$	18,202	$	(28,761)	Net income (loss)	$	13,727	$	11,058	$	31,929	$	(17,703)

Weighted average common shares outstanding – basic	Weighted average common shares outstanding – basic	21,555		21,869		21,743		21,848		Weighted average common shares outstanding – basic	21,242		21,905		21,574		21,868
Weighted average common stock equivalents	Weighted average common stock equivalents	316		247		362		0		Weighted average common stock equivalents	289		270		330		—
Weighted average common shares outstanding – diluted	Weighted average common shares outstanding – diluted	21,871		22,116		22,105		21,848		Weighted average common shares outstanding – diluted	21,531		22,175		21,904		21,868

Net earnings (loss) per basic share:	Net earnings (loss) per basic share:									Net earnings (loss) per basic share:
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	0.59	$	0.62	$	0.84	$	(1.31)	Net income (loss) from continuing operations	$	0.65	$	0.50	$	1.48	$	(0.81)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		0		0		(0.01)		Loss from discontinued operations, net of tax	—		—		—		—
Net income (loss)	Net income (loss)	$	0.59	$	0.62	$	0.84	$	(1.32)	Net income (loss)	$	0.65	$	0.50	$	1.48	$	(0.81)

Net earnings (loss) per diluted share:	Net earnings (loss) per diluted share:									Net earnings (loss) per diluted share:
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	0.59	$	0.61	$	0.82	$	(1.31)	Net income (loss) from continuing operations	$	0.64	$	0.50	$	1.46	$	(0.81)
Loss from discontinued operations, net of tax	Loss from discontinued operations, net of tax	0		0		0		(0.01)		Loss from discontinued operations, net of tax	—		—		—		—
Net income (loss)	Net income (loss)	$	0.59	$	0.61	$	0.82	$	(1.32)	Net income (loss)	$	0.64	$	0.50	$	1.46	$	(0.81)

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were ~~as follows:~~

As of June 30,
2021 2020
Unvested restricted stock awards 27 58
Total anti-dilutive securities 27 58
less than 0.1 million shares at both September 30, 2021 and 2020, and related to unvested restricted stock.

In November 2020, our board of directors authorized a share repurchase program (the “2020 Share Repurchase Program”) permitting us to

repurchase up to $50 million of our common stock through December 31, 2021. The 2020 Share Repurchase Program was authorized

subsequent to the expiration of our prior share repurchase program (the “2015 Share Repurchase Program”) on October 31, 2020. The 2015

Share Repurchase Program permitted us to repurchase up to $125 million of our common stock through October 31, 2020. During the third quarter of 2021, our board of directors authorized an extension of the 2020 Share Repurchase Program through December 31, 2022 and increased the authorized amount from $50 million to $100 million.The amount and timing of repurchases under both share repurchase programs were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. All shares repurchased and retired are reflected as a reduction to our basic weighted average shares outstanding based on the trade date of the share repurchase.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

In the three and ~~six~~nine months ended ~~June~~September 30, 2021, we repurchased and retired ~~405,363~~518,045 and ~~651,081~~1,169,126 shares for ~~$22.1~~$25.0 million and ~~$35.2~~$60.2 million, respectively, under the 2020 Share Repurchase Program. In the first quarter of 2020, we repurchased 313,998 shares for $20.9 million under the 2015 Share Repurchase Program. Additionally, in the first quarter of 2020, we settled the repurchase of 18,000 shares for $1.2 million that were accrued as of December 31, 2019. No shares were repurchased in the second ~~quarter~~or third quarters of 2020. As of ~~June~~September 30, 2021, ~~$9.7~~$34.7 million remained available for share repurchases under our 2020 Share Repurchase Program.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

7. Financing Arrangements

A summary of the carrying amounts of our debt follows:


	September 30, 2021		December 31, 2020
Senior secured credit facility	$	260,000	$	200,000
Promissory note due 2024	2,917		3,279
Total long-term debt	$	262,917	$	203,279
Current maturities of long-term debt	(555)		(499)
Long-term debt, net of current portion	$	262,362	$	202,780

June 30,
2021 December 31,
2020
Senior secured credit facility $ 265,000 $ 200,000
Promissory note due 2024 3,053 3,279
Total long-term debt $ 268,053 $ 203,279
Current maturities of long-term debt (551) (499)
Long-term debt, net of current portion $ 267,502 $ 202,780

Below is a summary of the scheduled remaining principal payments of our debt as of ~~June~~September 30, 2021.

Principal Payments of Long-Term Debt
2021 $ 273
2022 $ 559
2023 $ 575
2024 $ 266,646


	Principal Payments of Long-Term Debt
2021	$	137
2022	$	559
2023	$	575
2024	$	261,646

Senior Secured Credit Facility

The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of LIBOR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 upon the occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At ~~June~~September 30, 2021, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of ~~2.80~~2.73 to 1.00 and a Consolidated Interest Coverage Ratio of ~~13.83~~13.99 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at ~~June~~September 30, 2021 totaled ~~$265.0~~$260.0 million. These borrowings carried a weighted average interest rate of ~~2.4%~~2.7%, including the effect of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity."” Borrowings outstanding under the Amended Credit Agreement at December 31, 2020 were $200.0 million and carried a weighted average interest rate of 2.5%, including the effect of the interest rate swaps. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At ~~June~~September 30, 2021, we had outstanding letters of credit totaling $0.7 million, which are used as security deposits for our office facilities. As of ~~June~~September 30, 2021, the unused borrowing capacity under the revolving credit facility was ~~$334.3~~$339.3 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we pay interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At ~~June~~September 30, 2021, the outstanding principal amount of the promissory note was ~~$3.1~~$2.9 million, and the aircraft had a carrying amount of ~~$4.1~~$3.9 million. At December 31, 2020, the outstanding principal amount of the promissory note was $3.3 million, and the aircraft had a carrying amount of $4.4 million.

8. Restructuring Charges

Restructuring charges for the three and ~~six~~nine months ended ~~June~~September 30, 2021 were ~~$0.9~~$1.7 million and ~~$1.5~~$3.2 million, ~~respectively,~~respectively. The $1.7 million of restructuring charges recognized in the third quarter of 2021 consisted of $0.7 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business within our Business Advisory segment, $0.5 million of rent and ~~primarily~~related expenses, net of sublease income, for previously vacated office spaces, and $0.5 million of employee-related expenses. Of the $3.2 million restructuring charge incurred in the first nine months of 2021, $1.8 million related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office ~~spaces.~~spaces; $0.9 million related to third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business within our Business Advisory segment; and $0.5 million related to the employee-related expenses recognized in the third quarter of 2021.

Restructuring charges for the three and ~~six~~nine months ended ~~June~~September 30, 2020 were $0.1 million and ~~$1.7~~$1.8 million, respectively. The $0.1 million charge recognized in the third quarter of 2020 primarily related to rent and related expenses, net of sublease income, for vacated office spaces. Restructuring charges recognized in the first ~~six~~nine months of 2020 include a $1.2 million accrual for the termination of a third-party advisor agreement, $0.3 million related to workforce reductions to better align resources with market demand, $0.2 million related to rent and related expenses, net of sublease income, for vacated office spaces, and $0.1 million related to workforce reductions in our corporate operations.

In the fourth quarter of 2020, we announced a restructuring plan to reduce operating costs to address the impact of the COVID-19 pandemic on our business. The restructuring plan, which was substantially complete in the fourth quarter of 2020, provided for a reduction in certain leased office spaces and a reduction in workforce.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the ~~six~~nine months ended ~~June~~September 30, 2021.

Employee Costs Office Space Reductions Other Total
Balance as of December 31, 2020 $ 2,447 $ 84 $ 893 $ 3,424
Additions 4 0 200 204
Payments (2,438) (67) (266) (2,771)
Adjustments
(3) 0 0 (3)
Balance as of June 30, 2021 $ 10 $ 17 $ 827 $ 854


	Employee Costs		Office Space Reductions		Other		Total
Balance as of December 31, 2020	$	2,447	$	84	$	893	$	3,424
Additions	504		—		927		1,431
Payments	(2,438)		(84)		(707)		(3,229)
Adjustments	(13)		—		—		(13)
Balance as of September 30, 2021	$	500	$	—	$	1,113	$	1,613

The restructuring charge liability related to employee costs at ~~June~~September 30, 2021 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits. The employee related payments made in the first ~~six~~nine months of 2021 primarily related to the fourth quarter 2020 restructuring plan. ~~The restructuring charge liability related to office space reductions at June 30, 2021 is included as a component of accrued expenses and other current liabilities. The $0.8~~Of the $1.1 million other restructuring charge liability at ~~June~~September 30, 2021,$0.6 million is ~~primarily~~related to the divestiture of our Life Sciences business within our Business Advisory segment and is expected to be paid over the next 12 months and the remaining $0.5 million is related to the termination of a third-party advisor agreement ~~and is~~ expected to be paid over the next ~~19 months and is~~16 months. The other restructuring charge liabilities are included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities.

9. Derivative Instruments and Hedging Activity

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

On January 30, 2020, we entered into a forward interest rate swap agreement effective December 31, 2019 and ending December 31, 2024, with a notional amount of $50.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.500%.

On March 16, 2020, we entered into a forward interest rate swap agreement effective February 28, 2020 and ending February 28, 2025, with a notional amount of $100.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 0.885%.

We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated these derivative instruments as cash flow hedges. Therefore, changes in the fair value of the derivative instruments are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified into interest expense upon settlement. As of ~~June~~September 30, 2021, it was anticipated that $1.7 million of the losses, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.

The table below sets forth additional information relating to the interest rate swaps designated as a cash flow hedging instrument as of ~~June~~September 30, 2021 and December 31, 2020.

Fair Value (Derivative Asset and Liability)
Balance Sheet Location June 30,
2021 December 31,
2020
Accrued expenses and other current liabilities $ 2,046 $ 2,100
Deferred compensation and other liabilities $ 1,086 $ 3,297


	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	September 30, 2021		December 31, 2020


Accrued expenses and other current liabilities	$	2,051	$	2,100
Deferred compensation and other liabilities	$	660	$	3,297

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.

We do not use derivative instruments for trading or other speculative purposes. Refer to Note 11 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~We do not use derivative instruments for trading or other speculative purposes. Refer to Note 11 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.~~

10. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:


Level 1 Inputs						Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 Inputs						Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 Inputs						Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of ~~June~~September 30, 2021 and December 31, 2020.

Level 1 Level 2 Level 3 Total
June 30, 2021
Assets:
Convertible debt investment $ 0 $ 0 $ 59,972 $ 59,972
Deferred compensation assets 0 37,047 0 37,047
Total assets $ 0 $ 37,047 $ 59,972 $ 97,019
Liabilities:
Interest rate swaps $ 0 $ 3,132 $ 0 $ 3,132
Contingent consideration for business acquisition 0 0 1,812 1,812
Total liabilities $ 0 $ 3,132 $ 1,812 $ 4,944
December 31, 2020
Assets:
Convertible debt investment $ 0 $ 0 $ 64,364 $ 64,364
Deferred compensation assets 0 34,056 0 34,056
Total assets $ 0 $ 34,056 $ 64,364 $ 98,420
Liabilities:
Interest rate swaps $ 0 $ 5,397 $ 0 $ 5,397
Contingent consideration for business acquisition 0 0 1,770 $ 1,770
Total liabilities $ 0 $ 5,397 $ 1,770 $ 7,167


	Level 1		Level 2		Level 3		Total
September 30, 2021
Assets:

Convertible debt investment	$	—	$	—	$	61,549	$	61,549
Deferred compensation assets	—		37,195		—		37,195
Total assets	$	—	$	37,195	$	61,549	$	98,744
Liabilities:
Interest rate swaps	$	—	$	2,711	$	—	$	2,711
Contingent consideration for business acquisition	—		—		1,868		1,868
Total liabilities	$	—	$	2,711	$	1,868	$	4,579
December 31, 2020
Assets:

Convertible debt investment	$	—	$	—	$	64,364	$	64,364
Deferred compensation assets	—		34,056		—		34,056
Total assets	$	—	$	34,056	$	64,364	$	98,420
Liabilities:
Interest rate swaps	$	—	$	5,397	$	—	$	5,397
Contingent consideration for business acquisition	—		—		1,770		1,770
Total liabilities	$	—	$	5,397	$	1,770	$	7,167

Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. Refer to Note 9 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps.

Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt (the "initial convertible

notes"), in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. In the first quarter of 2020, we invested an additional $13.0 million, in the form of 1.69% convertible debt with a

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

senior liquidation preference to the initial convertible notes (the ~~"additional~~“additional convertible ~~note"~~note”) and amended our initial convertible notes to

extend the maturity date to January 17, 2024, which coincides with the maturity date of the additional convertible note.

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.

The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive

income. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the ~~probability weighted~~probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, ~~2024,~~2024; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 22.5% and 24.0% as of ~~June~~September 30, 2021 and December 31, 2020, respectively; and the concluded equity volatility of 45.0% as of both ~~June~~September 30, 2021 and December 31, 2020, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investments on our consolidated balance sheets.

The table below sets forth the changes in the balance of the convertible debt investment for the ~~six~~nine months ended ~~June~~September 30, 2021.


	Convertible Debt Investment
Balance as of December 31, 2020	$	64,364

Change in fair value of convertible debt investment	~~(4,392)~~(2,815)
Balance as of ~~June~~September 30, 2021	$	~~59,972~~61,549

Deferred compensation assets: We have a non-qualified deferred compensation plan (the ~~"Plan"~~“Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Contingent consideration for business acquisition: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which typically reflects a risk-free rate, and was 2.39% and 2.41% as of ~~June~~September 30, 2021 and December 31, 2020, respectively. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the ~~six~~nine months ended ~~June~~September 30, 2021.


	Contingent Consideration for Business Acquisitions
Balance as of December 31, 2020	$	1,770
Change in fair value of contingent consideration for business acquisition	4298
Balance as of ~~June~~September 30, 2021	$	~~1,812~~1,868

Financial assets and liabilities not recorded at fair value are as follows:

Preferred Stock Investment

In the fourth quarter of 2019, we invested $5.0 million, in the form of preferred stock, in Medically Home Group, Inc. ("(“Medically ~~Home"~~Home”), a healthcare technology-enabled services company. To determine the appropriate accounting treatment for our investment, we performed a

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

VIE analysis and concluded that Medically Home does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment in Medically Home to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment in Medically Home. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred, and remeasure the fair value of the preferred stock using such identified transactions, with changes in the fair value recorded in consolidated statement of operations. During the ~~six~~nine months ended ~~June~~September 30, 2021, there has been no impairment, nor any observable price change related to our investment. As of ~~June~~September 30, 2021, the carrying amount of our preferred stock investment was $6.7 million.

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 7 “Financing Arrangements” for additional information on our senior secured credit facility.

Promissory Note due 2024

The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 7 “Financing Arrangements” for additional information on our promissory note due 2024.

Cash and Cash Equivalents and Other Financial Instruments

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

11. Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three and nine months ended September 30, 2021 and 2020.


	Three Months Ended September 30, 2021						Three Months Ended September 30, 2020
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	(246)	$	—	$	(246)	$	381	$	—	$	381
Unrealized gain (loss) on investment	$	1,577	$	(419)	$	1,158	$	6,598	$	(1,713)	$	4,885
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	(192)	$	47	$	(145)	$	(903)	$	234	$	(669)
Reclassification adjustments into earnings	613		(159)		454		576		(150)		426
Net unrealized gain (loss)	$	421	$	(112)	$	309	$	(327)	$	84	$	(243)
Other comprehensive income (loss)	$	1,752	$	(531)	$	1,221	$	6,652	$	(1,629)	$	5,023

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~11. Other Comprehensive Income (Loss)~~

~~The table below sets forth the components of other comprehensive income (loss), net of tax, for the three and six months ended June 30, 2021 and 2020.~~

Three Months Ended
June 30, 2021 Three Months Ended
June 30, 2020
Before
Taxes Tax
(Expense)
Benefit Net of
Taxes Before
Taxes Tax
(Expense)
Benefit Net of
Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments $ 82 $ 0 $ 82 $ 104 $ 0 $ 104
Unrealized gain (loss) on investment $ 1,936 $ (514) $ 1,422 $ (7,670) $ 1,992 $ (5,678)
Unrealized gain (loss) on cash flow hedges:
Change in fair value $ (305) $ 78 $ (227) $ (2,640) $ 686 $ (1,954)
Reclassification adjustments into earnings 601 (156) 445 337 (88) 249
Net unrealized gain (loss) $ 296 $ (78) $ 218 $ (2,303) $ 598 $ (1,705)
Other comprehensive income (loss) $ 2,314 $ (592) $ 1,722 $ (9,869) $ 2,590 $ (7,279)


		Six Months Ended June 30, 2021						Six Months Ended June 30, 2020							Nine Months Ended September 30, 2021						Nine Months Ended September 30, 2020
		Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes			Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Other comprehensive income (loss):	Other comprehensive income (loss):													Other comprehensive income (loss):
Foreign currency translation adjustments	Foreign currency translation adjustments	$	482	$	0	$	482	$	(675)	$	0	$	(675)	Foreign currency translation adjustments	$	236	$	—	$	236	$	(294)	$	—	$	(294)
Unrealized gain (loss) on investment	Unrealized gain (loss) on investment	$	(4,392)	$	1,166	$	(3,226)	$	(8,018)	$	2,082	$	(5,936)	Unrealized gain (loss) on investment	$	(2,815)	$	747	$	(2,068)	$	(1,420)	$	369	$	(1,051)
Unrealized gain (loss) on cash flow hedges:	Unrealized gain (loss) on cash flow hedges:													Unrealized gain (loss) on cash flow hedges:
Change in fair value	Change in fair value	$	884	$	(259)	$	625	$	(4,912)	$	1,276	$	(3,636)	Change in fair value	$	692	$	(212)	$	480	$	(5,815)	$	1,510	$	(4,305)
Reclassification adjustments into earnings	Reclassification adjustments into earnings	1,381		(359)		1,022		333		(87)		246		Reclassification adjustments into earnings	1,994		(518)		1,476		909		(237)		672
Net unrealized gain (loss)	Net unrealized gain (loss)	$	2,265	$	(618)	$	1,647	$	(4,579)	$	1,189	$	(3,390)	Net unrealized gain (loss)	$	2,686	$	(730)	$	1,956	$	(4,906)	$	1,273	$	(3,633)
Other comprehensive income (loss)	Other comprehensive income (loss)	$	(1,645)	$	548	$	(1,097)	$	(13,272)	$	3,271	$	(10,001)	Other comprehensive income (loss)	$	107	$	17	$	124	$	(6,620)	$	1,642	$	(4,978)

The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.

Accumulated other comprehensive income, net of tax, includes the following components:


		Foreign Currency Translation		Available-for-Sale Investment		Cash Flow Hedges		Total			Foreign Currency Translation		Available-for-Sale Investment		Cash Flow Hedges		Total
Balance, December 31, 2020	Balance, December 31, 2020	$	(218)	$	17,205	$	(3,926)	$	13,061	Balance, December 31, 2020	$	(218)	$	17,205	$	(3,926)	$	13,061
Current period change	Current period change	482		(3,226)		1,647		(1,097)		Current period change	236		(2,068)		1,956		124
Balance, June 30, 2021		$	264	$	13,979	$	(2,279)	$	11,964
Balance, September 30, 2021										Balance, September 30, 2021	$	18	$	15,137	$	(1,970)	$	13,185

12. Income Taxes

For the three months ended September 30, 2020, our effective tax rate was 17.7% as we recognized income tax expense from continuing operations of $2.4 million on income from continuing operations of $13.5 million. The effective tax rate of 17.7% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to the year-to-date pre-tax losses and the impact during the quarter of certain nondeductible expense items, including the nondeductible portion of the goodwill impairment charges, based on the attribution of those expenses to the quarter in accordance with the allocation of income tax expense on a year-to-date basis. The effective tax rate also reflected the positive impact of certain federal tax credits.

For the nine months ended September 30, 2021, our effective tax rate was 17.9% as we recognized income tax expense from continuing operations of $7.0 million on income from continuing operations of $38.9 million. The effective tax rate of 17.9% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to the discrete tax benefit during the third quarter of 2021 for U.S. federal return to provision adjustment related to the 2020 corporate income tax return. The effective tax rate also reflected the positive impact of certain federal tax credits and a discrete tax benefit recognized during the second quarter of 2021 related to electing the Global Intangible ~~Low- Taxed~~Low-Taxed Income ~~(“GILTI”~~("GILTI") high-tax exclusion retroactively for the 2018 tax year. On July 20, 2020, the U.S. Treasury issued and enacted final regulations related to GILTI that allow certain U.S. taxpayers to elect to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. The GILTI high-tax exclusion is an annual election and is retroactively available. ~~This~~These favorable ~~item was~~items were partially offset by certain nondeductible ~~expense items.~~business expenses.

For the nine months ended September 30, 2020, our effective tax rate was 23.5% as we recognized an income tax benefit from continuing operations of $5.4 million on a loss from continuing operations of $23.0 million. The effective tax rate of 23.5% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to certain nondeductible business expenses and the nondeductible portion of the goodwill impairment charges recorded during the first quarter of 2020. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested primarily during the first quarter, the positive impact of certain federal

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~For the three months ended June 30, 2020, our effective~~ tax rate was 20.1% as we recognized an income tax expense from continuing operations of $3.4 million on income from continuing operations of $17.0 million. The effective tax rate of 20.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to the current year-to-date pre-tax losses and the impact during the quarter of certain nondeductible expense items, including the nondeductible portion of the goodwill impairment charges, based on the attribution of those expenses to the quarter in accordance with the allocation of income tax expense on a current year-to-date basis. The effective tax rate also reflected the positive impact of certain federal tax credits.

For the six months ended June 30, 2021, our effective tax rate was 21.5% as we recognized income tax expense from continuing operations of $5.0 million on income from continuing operations of $23.2 million. The effective tax rate of 21.5% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to the discrete tax benefit related to electing the GILTI high-tax exclusion retroactively for the 2018 tax year and a discrete tax benefit for share-based compensation awards that vested during the first quarter. These favorable items were partially offset by certain nondeductible expense items.

For the six months ended June 30, 2020, our effective tax rate was 21.4% as we recognized an income tax benefit from continuing operations of $7.8 million on a loss from continuing operations of $36.5 million. The effective tax rate of 21.4% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to certain nondeductible expense items and the nondeductible portion of the goodwill impairment charges recorded during the first quarter of 2020. These unfavorable items were partially offset by a discrete tax benefit for share-based compensation awards that vested during the first quartercredits and the discrete tax benefit for the remeasurement of a portion of our income tax receivable as a result of the enactment of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) in the first quarter of 2020.

The CARES Act, which was signed into law on March 27, 2020, is an approximately $2 trillion emergency economic stimulus package in response to the COVID-19 outbreak, which among other items, includes income tax provisions relating to net operating loss carryback periods and technical corrections to tax depreciation methods for qualified improvement property. ~~During~~In the first nine months of 2020, as a result of the CARES Act, we recognized a ~~$1.5~~$0.8 million tax benefit related to the remeasurement of a portion of our income tax receivable ~~for~~due to the ability to apply the federal net operating loss incurred in 2018 ~~and the expected federal net operating loss in 2020 that will be carried back~~ to prior year income ~~both~~ for a refund at the higher ~~prior year~~ tax ~~rate.~~rate in the carryback period. As a result of electing the retroactive GILTI high-tax exclusion ~~during~~in the second quarter of 2021, we recognized a $1.0 million tax benefit of which $0.4 million related to carrying back our increased 2018 federal net operating loss to prior year income for a refund at the higher, prior year tax rate. During the third quarter of 2021, we recognized an additional tax benefit of $2.0 million, primarily related to the U.S. federal return to provision adjustments for carrying back our increased 2020 federal net operating loss to prior year income for a refund at the higher, prior year tax rate.

13. Commitments, Contingencies and Guarantees

Litigation

Oaktree

On November 9, 2018, Huron Consulting Services LLC, a wholly owned subsidiary of Huron, was engaged by Oaktree Medical Centre LLC, a management services organization (“Oaktree”), to perform interim management and financial advisory services. As part of the services, a Huron employee was appointed by Oaktree’s board of directors to serve as Chief Restructuring Officer of Oaktree (the ~~"CRO"~~“CRO”). The engagement letter through which Oaktree retained Huron’s services (the ~~"Engagement Letter"~~“Engagement Letter”) states that all disputes or claims arising thereunder are subject to binding arbitration, disclaims special, consequential, incidental and exemplary damages and losses and caps liability to the fees paid for the portion of the engagement giving rise to any liability. On September 19, 2019, Oaktree and certain of its affiliates filed for Chapter 7 liquidation in the U.S. Bankruptcy Court for the Western District of North Carolina, with the cases subsequently transferred to the District of South Carolina. As a result of the bankruptcy filing, a Chapter 7 trustee was appointed to oversee the bankruptcy estates, at which time Huron’s services for Oaktree concluded.

In April 2021, Trustee’s counsel communicated in writing to Huron its intent to pursue various claims against Huron and the CRO, among others, on behalf of the bankruptcy estates related to the services carried out by Huron and the CRO during the engagement. ~~Trustee's counsel has subsequently asserted that certain provisions~~

On September 17, 2021, the Trustee filed a complaint in the ~~Engagement Letter are unenforceable and/or inapplicable~~Bankruptcy Court for the District of South Carolina against Huron and the CRO, among others (the “Complaint”), alleging breach of fiduciary duty, aiding and abetting a breach of fiduciary duty, negligence, violations of the South Carolina Unfair Trade Practices Act, fraud, civil conspiracy, unjust enrichment, and recovery of avoided transfers under sections 547, 548 and 550 of the Bankruptcy Code. In the Complaint, the Trustee asserts that Huron and the CRO, among others, did not develop and implement a Chapter 11 restructuring plan on a timely basis and that their failure to do so led to significant damages. The Trustee seeks an unspecified amount of monetary damages in the Complaint. We believe the Trustee’s allegations with respect to Huron and the CRO are without merit and will vigorously defend ourselves ~~should any claim arising out of these alleged facts and circumstances be asserted~~ against ~~us by~~ the ~~Trustee.~~allegations raised in the Complaint. Notwithstanding the foregoing, given the inherent risk and uncertainty associated with all litigation, we cannot estimate the potential liability with respect to such allegations at this time.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling $0.7 million and $1.6 million were outstanding at ~~June~~September 30, 2021 and December 31, 2020, respectively, primarily to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of ~~June~~September 30, 2021 and December 31, 2020, the total estimated fair value of our outstanding contingent consideration liability was $1.9 million and $1.8 ~~million.~~million, respectively.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

14. Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under 3 operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.

•Healthcare

Our Healthcare segment serves national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. Our Healthcare professionals have a depth of expertise in business operations, including financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions. Most healthcare organizations are focused on changing the way care is delivered; establishing a sustainable business model centered around optimal cost structures, reimbursement models and financial strategies; and evolving their digital, technology and analytic capabilities. Our solutions help clients adapt to this rapidly changing healthcare environment to become a more agile, efficient and consumer-centric organization. We use our deep industry expertise to help clients solve a diverse set of business issues, including, but not limited to, optimizing financial and operational performance, improving care delivery and clinical outcomes, increasing physician, patient and employee satisfaction, evolving organizational culture, and maximizing return on technology investments.

•Business Advisory

Our Business Advisory segment works with C-suite executives, boards, and business unit and functional leadership across a diverse set of organizations, including healthy, well-capitalized companies to organizations in transition, and across a broad range of industries, including ~~life sciences,~~ financial services, healthcare, education, energy and utilities, industrials and manufacturing, and the public sector. Our Business Advisory professionals have deep industry, functional and technical expertise that they put forward when delivering our digital, technology and analytics, strategy and innovation and corporate finance and restructuring services. In today’s disruptive environment, organizations must reimagine their historical strategies and financial and operating models to sustain and advance their competitive advantage. Organizations also recognize the need to adopt technologies, automation and analytics to improve their operations and compete in a rapidly changing environment. Our experts help organizations across industries with a variety of business challenges, including, but not limited to, embedding technology and analytics throughout their internal and customer-facing operations, developing insights into the needs of tomorrow’s customers in order to evolve their enterprise and business unit strategies, bringing new products to market, and managing through stressed and distressed situations to create a viable path forward for stakeholders.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

•Education

Our Education segment serves public and private colleges and universities, academic medical centers, research institutes and other not-for-profit organizations. Our Education professionals have a depth of expertise in strategy and innovation; business operations, including the research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation. Our Education segment clients are increasingly faced with financial and/or demographic challenges as well as increased competition. To remain competitive, organizations must challenge traditional operating and financial models and reimagine strategic, operational and research-centered opportunities that advance their mission while strengthening their business models. We collaborate with clients to address these challenges and ensure they have a sustainable future. We combine our deep industry, functional and technical expertise to help clients solve their most pressing challenges, including, but not limited to, transforming business operations with technology; strengthening research strategies and support services; evolving their organizational strategy; optimizing financial and operational performance; and enhancing the student lifecycle.

Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.

The table below sets forth information about our operating segments for the three and ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,						Nine Months Ended September 30,
		2021			2020			2021			2020				2021			2020			2021			2020
Healthcare:	Healthcare:													Healthcare:
Revenues	Revenues	$	101,357		$	85,356		$	181,079		$	180,934		Revenues	$	92,845		$	87,406		$	273,924		$	268,340
Operating income	Operating income	$	27,624		$	21,171		$	48,108		$	45,221		Operating income	$	30,255		$	25,610		$	78,363		$	70,831
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	27.3		%	24.8		%	26.6		%	25.0		%	Segment operating income as a percentage of segment revenues	32.6		%	29.3		%	28.6		%	26.4		%
Business Advisory:	Business Advisory:													Business Advisory:
Revenues	Revenues	$	70,908		$	70,470		$	143,775		$	135,375		Revenues	$	69,966		$	66,048		$	213,741		$	201,423
Operating income	Operating income	$	14,315		$	16,684		$	27,392		$	26,526		Operating income	$	9,892		$	10,780		$	37,284		$	37,306
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	20.2		%	23.7		%	19.1		%	19.6		%	Segment operating income as a percentage of segment revenues	14.1		%	16.3		%	17.4		%	18.5		%
Education:	Education:													Education:
Revenues	Revenues	$	57,861		$	62,031		$	108,485		$	124,167		Revenues	$	61,196		$	51,850		$	169,681		$	176,017
Operating income	Operating income	$	13,770		$	16,128		$	22,423		$	29,244		Operating income	$	14,788		$	12,548		$	37,211		$	41,792
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	23.8		%	26.0		%	20.7		%	23.6		%	Segment operating income as a percentage of segment revenues	24.2		%	24.2		%	21.9		%	23.7		%
Total Company:	Total Company:													Total Company:
Revenues	Revenues	$	230,126		$	217,857		$	433,339		$	440,476		Revenues	$	224,007		$	205,304		$	657,346		$	645,780
Reimbursable expenses	Reimbursable expenses	3,252			2,970			5,186			22,273			Reimbursable expenses	3,690			2,860			8,876			25,133
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	$	233,378		$	220,827		$	438,525		$	462,749		Total revenues and reimbursable expenses	$	227,697		$	208,164		$	666,222		$	670,913

Segment operating income	Segment operating income	$	55,709		$	53,983		$	97,923		$	100,991		Segment operating income	$	54,935		$	48,938		$	152,858		$	149,929
Items not allocated at the segment level:	Items not allocated at the segment level:													Items not allocated at the segment level:
Other operating expenses	Other operating expenses	34,325			31,638			63,162			58,784			Other operating expenses	31,374			29,042			94,536			87,826
Litigation and other losses (gains)	Litigation and other losses (gains)	0			0			42			(150)			Litigation and other losses (gains)	56			—			98			(150)
Depreciation and amortization	Depreciation and amortization	5,255			6,391			10,350			12,438			Depreciation and amortization	5,199			6,197			15,549			18,635
Goodwill impairment charges1	Goodwill impairment charges1	0			0			0			59,816			Goodwill impairment charges1	—			—			—			59,816
Other expense (income), net		(122)			(1,032)			1,177			6,605
Other expense, net														Other expense, net	2,611			224			3,788			6,829
Income (loss) from continuing operations before taxes	Income (loss) from continuing operations before taxes	$	16,251		$	16,986		$	23,192		$	(36,502)		Income (loss) from continuing operations before taxes	$	15,695		$	13,475		$	38,887		$	(23,027)

(1) The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.

2019

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our 3 operating segments for the three and ~~six~~nine months ended ~~June~~September 30, 2021 and 2020.

In conjunction with our continuous evaluation of the appropriate level of disaggregation of revenues as our business evolves and in consideration of a group hire of approximately 300 employees in our Healthcare Managed Services solution within our Healthcare segment in the second quarter of 2021, we began assessing our operating performance by the following three employee types: billable consultants, full-time equivalents, and Healthcare Managed Services employees. The disaggregation of revenues by employee type previously reported for the three and ~~six~~nine months ended ~~June~~September 30, 2020 was revised below to reflect this change. This change has no impact on our consolidated total revenues or total revenues by segment.


		Three Months Ended June 30, 2021									Three Months Ended September 30, 2021
		Healthcare		Business Advisory		Education		Total			Healthcare		Business Advisory		Education		Total
Billing Arrangements	Billing Arrangements									Billing Arrangements
Fixed-fee	Fixed-fee	$	55,095	$	31,350	$	17,886	$	104,331	Fixed-fee	$	56,836	$	30,783	$	14,985	$	102,604
Time and expense	Time and expense	18,039		35,988		33,039		87,066		Time and expense	17,823		35,261		38,831		91,915
Performance-based	Performance-based	23,061		1,517		0		24,578		Performance-based	12,689		1,596		—		14,285
Software support, maintenance and subscriptions	Software support, maintenance and subscriptions	5,162		2,053		6,936		14,151		Software support, maintenance and subscriptions	5,497		2,326		7,380		15,203
Total	Total	$	101,357	$	70,908	$	57,861	$	230,126	Total	$	92,845	$	69,966	$	61,196	$	224,007

Employee Type (1)	Employee Type (1)									Employee Type (1)
Revenue generated by billable consultants	Revenue generated by billable consultants	$	66,810	$	66,051	$	49,291	$	182,152	Revenue generated by billable consultants	$	59,502	$	64,469	$	51,237	$	175,208
Revenue generated by full-time equivalents	Revenue generated by full-time equivalents	20,498		4,857		8,570		33,925		Revenue generated by full-time equivalents	19,731		5,497		9,959		35,187
Revenue generated by Healthcare Managed Services employees	Revenue generated by Healthcare Managed Services employees	14,049		—		—		14,049		Revenue generated by Healthcare Managed Services employees	13,612		—		—		13,612
Total	Total	$	101,357	$	70,908	$	57,861	$	230,126	Total	$	92,845	$	69,966	$	61,196	$	224,007

Timing of Revenue Recognition	Timing of Revenue Recognition									Timing of Revenue Recognition
Revenue recognized over time	Revenue recognized over time	$	99,884	$	70,908	$	57,861	$	228,653	Revenue recognized over time	$	91,800	$	69,966	$	60,921	$	222,687
Revenue recognized at a point in time	Revenue recognized at a point in time	1,473		0		0		1,473		Revenue recognized at a point in time	1,045		—		275		1,320
Total	Total	$	101,357	$	70,908	$	57,861	$	230,126	Total	$	92,845	$	69,966	$	61,196	$	224,007


		Six Months Ended June 30, 2021									Nine Months Ended September 30, 2021
		Healthcare		Business Advisory		Education		Total			Healthcare		Business Advisory		Education		Total
Billing Arrangements	Billing Arrangements									Billing Arrangements
Fixed-fee	Fixed-fee	$	103,390	$	61,231	$	33,145	$	197,766	Fixed-fee	$	160,226	$	92,014	$	48,130	$	300,370
Time and expense	Time and expense	29,414		73,621		61,823		164,858		Time and expense	47,237		108,882		100,654		256,773
Performance-based	Performance-based	37,730		4,926		0		42,656		Performance-based	50,419		6,522		—		56,941
Software support, maintenance and subscriptions	Software support, maintenance and subscriptions	10,545		3,997		13,517		28,059		Software support, maintenance and subscriptions	16,042		6,323		20,897		43,262
Total	Total	$	181,079	$	143,775	$	108,485	$	433,339	Total	$	273,924	$	213,741	$	169,681	$	657,346

Employee Type (1)	Employee Type (1)									Employee Type (1)
Revenue generated by billable consultants	Revenue generated by billable consultants	$	118,555	$	135,898	$	91,819	$	346,272	Revenue generated by billable consultants	$	178,057	$	200,367	$	143,056	$	521,480
Revenue generated by full-time equivalents	Revenue generated by full-time equivalents	40,727		7,877		16,666		65,270		Revenue generated by full-time equivalents	60,458		13,374		26,625		100,457
Revenue generated by Healthcare Managed Services employees	Revenue generated by Healthcare Managed Services employees	21,797		—		—		21,797		Revenue generated by Healthcare Managed Services employees	35,409		—		—		35,409
Total	Total	$	181,079	$	143,775	$	108,485	$	433,339	Total	$	273,924	$	213,741	$	169,681	$	657,346

Timing of Revenue Recognition	Timing of Revenue Recognition									Timing of Revenue Recognition
Revenue recognized over time	Revenue recognized over time	$	178,648	$	143,775	$	108,485	$	430,908	Revenue recognized over time	$	270,448	$	213,741	$	169,406	$	653,595
Revenue recognized at a point in time	Revenue recognized at a point in time	2,431		0		0		2,431		Revenue recognized at a point in time	3,476		—		275		3,751
Total	Total	$	181,079	$	143,775	$	108,485	$	433,339	Total	$	273,924	$	213,741	$	169,681	$	657,346

2120

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)


		Three Months Ended June 30, 2020									Three Months Ended September 30, 2020
		Healthcare		Business Advisory		Education		Total			Healthcare		Business Advisory		Education		Total
Billing Arrangements	Billing Arrangements									Billing Arrangements
Fixed-fee	Fixed-fee	$	50,803	$	27,374	$	11,397	$	89,574	Fixed-fee	$	51,491	$	20,675	$	10,958	$	83,124
Time and expense	Time and expense	14,029		40,264		44,568		98,861		Time and expense	14,627		40,511		35,214		90,352
Performance-based	Performance-based	14,480		1,586		695		16,761		Performance-based	15,641		3,671		—		19,312
Software support, maintenance and subscriptions	Software support, maintenance and subscriptions	6,044		1,246		5,371		12,661		Software support, maintenance and subscriptions	5,647		1,191		5,678		12,516
Total	Total	$	85,356	$	70,470	$	62,031	$	217,857	Total	$	87,406	$	66,048	$	51,850	$	205,304

Employee Type (1)	Employee Type (1)									Employee Type (1)
Revenue generated by billable consultants	Revenue generated by billable consultants	$	55,249	$	67,269	$	53,187	$	175,705	Revenue generated by billable consultants	$	60,034	$	62,340	$	44,234	$	166,608
Revenue generated by full-time equivalents	Revenue generated by full-time equivalents	22,821		3,201		8,844		34,866		Revenue generated by full-time equivalents	20,949		3,708		7,616		32,273
Revenue generated by Healthcare Managed Services employees	Revenue generated by Healthcare Managed Services employees	7,286		—		—		7,286		Revenue generated by Healthcare Managed Services employees	6,423		—		—		6,423
Total	Total	$	85,356	$	70,470	$	62,031	$	217,857	Total	$	87,406	$	66,048	$	51,850	$	205,304

Timing of Revenue Recognition	Timing of Revenue Recognition									Timing of Revenue Recognition
Revenue recognized over time	Revenue recognized over time	$	84,941	$	70,470	$	62,030	$	217,441	Revenue recognized over time	$	86,413	$	66,048	$	51,663	$	204,124
Revenue recognized at a point in time	Revenue recognized at a point in time	415		0		1		416		Revenue recognized at a point in time	993		—		187		1,180
Total	Total	$	85,356	$	70,470	$	62,031	$	217,857	Total	$	87,406	$	66,048	$	51,850	$	205,304


		Six Months Ended June 30, 2020									Nine Months Ended September 30, 2020
		Healthcare		Business Advisory		Education		Total			Healthcare		Business Advisory		Education		Total
Billing Arrangements	Billing Arrangements									Billing Arrangements
Fixed-fee	Fixed-fee	$	106,588	$	52,767	$	24,572	$	183,927	Fixed-fee	$	158,079	$	73,442	$	35,530	$	267,051
Time and expense	Time and expense	28,762		77,853		88,279		194,894		Time and expense	43,389		118,364		123,493		285,246
Performance-based	Performance-based	33,401		2,232		695		36,328		Performance-based	49,042		5,903		695		55,640
Software support, maintenance and subscriptions	Software support, maintenance and subscriptions	12,183		2,523		10,621		25,327		Software support, maintenance and subscriptions	17,830		3,714		16,299		37,843
Total	Total	$	180,934	$	135,375	$	124,167	$	440,476	Total	$	268,340	$	201,423	$	176,017	$	645,780

Employee Type (1)	Employee Type (1)									Employee Type (1)
Revenue generated by full-time billable consultants		$	117,115	$	129,226	$	106,623	$	352,964
Revenue generated by billable consultants										Revenue generated by billable consultants	$	177,149	$	191,566	$	150,857	$	519,572
Revenue generated by full-time equivalents	Revenue generated by full-time equivalents	48,749		6,149		17,544		72,442		Revenue generated by full-time equivalents	69,698		9,857		25,160		104,715
Revenue generated by Healthcare Managed Services employees	Revenue generated by Healthcare Managed Services employees	15,070		—		—		15,070		Revenue generated by Healthcare Managed Services employees	21,493		—		—		21,493
Total	Total	$	180,934	$	135,375	$	124,167	$	440,476	Total	$	268,340	$	201,423	$	176,017	$	645,780

Timing of Revenue Recognition	Timing of Revenue Recognition									Timing of Revenue Recognition
Revenue recognized over time	Revenue recognized over time	$	179,400	$	135,375	$	124,052	$	438,827	Revenue recognized over time	$	265,813	$	201,423	$	175,715	$	642,951
Revenue recognized at a point in time	Revenue recognized at a point in time	1,534		0		115		1,649		Revenue recognized at a point in time	2,527		—		302		2,829
Total	Total	$	180,934	$	135,375	$	124,167	$	440,476	Total	$	268,340	$	201,423	$	176,017	$	645,780

(1) Billable consultants consist of our consulting professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients. Healthcare Managed Services employees manage and provide revenue cycle billing, collections, insurance verification and change integrity services to healthcare clients.

At ~~June~~September 30, 2021 ~~one client in our Healthcare segment had a total receivable~~ and unbilled services balance that accounted for 10.4%of our combined balance of receivables from clients, net and unbilled services, net. The outstanding balance for this client is the result of outstanding invoices due in the normal course of the contract payment terms and services performed in advance of the contract billing schedule. At December 31, 2020, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, net. During the three and nine months ended September 30, 2021 and 2020, no single client generated greater than 10% of our consolidated revenues.

2221

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

15. Subsequent Event

On November 1, 2021, we completed the divestiture of our Life Sciences business to Oliver Wyman. The Life Sciences business, a reporting unit within the Business Advisory segment, provides commercial and ~~unbilled services, net. During~~research and development strategy, pricing and market access strategy solutions to customers in the life sciences industries. For the three and ~~six~~nine months ended ~~June~~September 30, 2021, Life Sciences revenues were $5.1 million and ~~2020, no single client generated greater than 10% of~~$14.8 million, respectively. The Life Sciences business is not significant to our consolidated ~~revenues.~~financial statements and does not qualify as a discontinued operation for reporting under GAAP.

2322

Table of Contents


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy, our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates, and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2020 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

Huron is a global consultancy that collaborates with clients to drive strategic growth, ignite innovation and navigate constant change. Through a combination of strategy, expertise and creativity, we help clients accelerate operational, digital and cultural transformation, enabling the change they need to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.

We provide professional services through three operating segments: Healthcare, Business Advisory, and Education.

•Healthcare

•Business Advisory

2423

Table of Contents

•Education

Huron is an Oracle partner, a Gold-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org, a Workday Services and Software Partner, an Amazon Web Services consulting partner, a Silver-level system integrator with Informatica and an SAP Concur implementation partner.

Coronavirus (COVID-19)

The worldwide spread of COVID-19 beginning in 2020 has created significant volatility, uncertainty and disruption to the global economy. This pandemic ~~has~~ had an unfavorable impact on aspects of our business, operations, and financial results, and ~~has~~ caused us to significantly change the way we operate. Near the end of the first quarter of 2020, we suspended almost all business travel and our employees began working from their homes. While traditionally a majority of the work performed by our revenue-generating professionals occurred at client sites, the nature of the services we provide and enhanced available technology allows our revenue-generating professionals to effectively serve clients in a remote work environment. As federal, state and local ~~governments ease their~~government restrictions evolve, we continue to refine our comprehensive plan to return to our offices and client sites with our people’s safety and the needs of our clients guiding how we implement our phased transition. As of ~~June~~September 30, 2021, our employees continue to primarily work from their homes; however, most of our offices are open and we are providing our employees the flexibility to choose to work remotely, from our offices, or from client sites as needed and in accordance with recommended public health guidelines.

In each of our operating segments, we are working closely with our clients to support them and their ongoing business needs and provide relevant services to address their needs caused by the COVID-19 pandemic. However, since the beginning of the pandemic, some clients reprioritized and delayed projects which negatively impacted demand for certain offerings, particularly within our Healthcare and Education segments. Conversely, the COVID-19 pandemic strengthened demand for other services we provide, such as our cloud-based technology and analytics solutions within our Business Advisory segment and our restructuring and capital advisory solutions provided to organizations in transition also within our Business Advisory segment.

InBeginning in the second quarter of 2021 and continuing through the third quarter of 2021, we saw strengthened demand for services in all of our ~~Healthcare and Business Advisory segments.~~segments compared to the same prior year period. As a result, ~~while~~ total revenues in the first ~~six~~nine months of 2021 ~~decreased 1.6%~~increased 1.8% compared to the first ~~six~~nine months of 2020, and total revenues in the ~~second~~third quarter of 2021 increased ~~5.6%~~9.1% compared to the ~~second~~third quarter of ~~2020 and increased 13.2% from the first quarter of 2021, and we~~2020. We expect continued revenue growth in the ~~second half~~fourth quarter of 2021 compared to the ~~second half~~fourth quarter of 2020.

In order to support our liquidity during the COVID-19 pandemic, we took proactive measures to increase available cash on hand including, but not limited to, borrowing under our senior secured credit facility in the first quarter of 2020 and reducing discretionary operating and capital spending. In the second, third and fourth quarters of 2020, we made repayments on our borrowings to reduce our total debt outstanding to pre-pandemic levels due to our ability to maintain adequate cash flows from operations and improved clarity around access to capital resources. In the first ~~six~~nine months of 2021, we borrowed under our credit facility primarily to fund our annual performance bonus payment. To further support our liquidity during the COVID-19 pandemic, we elected to defer the deposit of our employer portion of social security taxes beginning in April 2020 and through December 31, 2020, as provided for under the CARES Act. These deferred payments, ~~are due~~which totaled $12.2 million, were paid in ~~equal installments~~full in the ~~fourth quarters~~third quarter of ~~2021 and 2022.~~2021. See the “Liquidity and Capital Resources” section below for additional information on these items.

Enterprise Resource Planning System Implementation

In the fourth quarter of 2019, we began the implementation of a new cloud-based enterprise resource planning (“ERP”) system designed to improve the efficiency of our internal finance, human resources, resource planning, and administrative operations. In January 2021, we successfully went live with the new ERP system, and we continue to progress with additional functionality and integrations as scheduled. The implementation progressed on schedule and was not significantly impacted by the COVID-19 pandemic due to the ability of our implementation team to work and collaborate remotely and the enhanced technology and cloud-based nature of our new ERP system. We believe our investment in this new system will position our teams to drive efficiencies and provide more robust management reporting and data analytics to support future growth and the goals and vision of the company.

2524

Table of Contents

How We Generate Revenues

A large portion of our revenues is generated by our billable consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, some of whom work variable schedules as needed by our clients. Full-time equivalent professionals consist of our coaches and their support staff from our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, and our employees who provide software support and maintenance services to our clients. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. Another portion of our revenue is generated by our Healthcare Managed Services employees within our Healthcare segment. Our Healthcare Managed Services employees manage and provide revenue cycle billing, collections, insurance verification and change integrity services to clients. We refer to our billable consultants, full-time equivalents and Healthcare Managed Services employees as revenue-generating professionals.

Revenues generated by our billable consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked, and billing rates charged. Revenues generated by our coaches are largely dependent on the number of coaches we employ and the total value, scope, and terms of the consulting contracts under which they provide services, which are primarily fixed-fee contracts. Revenues generated by our Healthcare Managed Services employees are largely dependent on the number of Healthcare Managed Services employees we employ and the total value, scope and terms of the related contracts.

We generate our revenues from providing professional services under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.

In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. It is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to-date versus our estimates of the total services to be provided under the engagement. Contracts within our Culture and Organizational Excellence solution include fixed-fee partner contracts with multiple performance obligations (“Partner Contracts”), which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software products. Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided.

Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software. Licenses for our revenue cycle management software are sold only as a component of our consulting projects, and the services we provide are essential to the functionality of the software. Therefore, revenues from these software licenses are recognized over the term of the related consulting services contract. License revenue from our research administration and compliance software is generally recognized in the month in which the software is delivered.

Fixed-fee engagements represented ~~45.3%~~45.8% and ~~41.1%~~40.5% of our revenues for the three months ended ~~June~~September 30, 2021 and 2020, respectively, and ~~45.6%~~45.7% and ~~41.8%~~41.3% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively.

Time-and-expense billing arrangements require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences and publications purchased by our clients outside of Partner Contracts within our Culture and Organizational Excellence solution and the portion of our Healthcare Managed Services contracts that are billed under time-and-expense arrangements. We recognize revenues under time-and-expense billing arrangements as the related services or publications are provided. Time-and-expense engagements represented ~~37.8%~~41.0% and ~~45.4%~~44.0% of our revenues for the three months ended ~~June~~September 30, 2021 and 2020, respectively, and ~~38.0%~~39.1% and 44.2% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively.

In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our time-and-expense or fixed-fee engagements. We recognize revenues under performance-based billing arrangements by estimating the amount of variable consideration that is probable of being earned and recognizing that estimate over the length of the contract using a proportionate performance approach. Performance-based fee revenues represented ~~10.7%~~6.4% and ~~7.7%~~9.4% of our revenues for the three months ended ~~June~~September 30, 2021 and 2020, respectively, and ~~9.9%~~8.6% and ~~8.3%~~8.6% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively. The level of performance-based fees earned may vary based on our clients' risk sharing preferences and the mix of services we provide.

Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, maintenance and subscription revenues are recognized

Table of Contents

ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized.

~~Table of Contents~~

Software support, maintenance and subscription revenues represented ~~6.2%~~6.8% and ~~5.8%~~6.1% of our revenues for the three months ended ~~June~~September 30, 2021 and 2020, respectively, and ~~6.5%~~6.6% and ~~5.7%~~5.9% of our revenues for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively.

Our quarterly results are impacted principally by our billable consultants’ utilization rate, the bill rates we charge our clients, and the number of our revenue-generating professionals who are available to work. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Business Strategy, Opportunities and Challenges

Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we continue to hire highly qualified professionals and have entered into select acquisitions of complementary businesses.

To expand our business, we will remain focused on growing our existing relationships and developing new relationships, executing our managing director compensation plan to attract and retain senior practitioners, continuing to promote and provide an integrated approach to service delivery, broadening the scope of our existing services, and acquiring complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, and endorsed messages.

2726

Table of Contents

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data.

In conjunction with our continuous evaluation of the appropriate level of disaggregation of revenues as our business evolves and in consideration of a group hire of approximately 300 employees in our Healthcare Managed Services solution within our Healthcare segment in the second quarter of 2021, we began assessing our operating performance by the following three employee types: billable consultants, full-time equivalents, and Healthcare Managed Services employees. The other operating data previously reported for the three and ~~six~~nine months ended ~~June~~September 30, 2020 was revised below to reflect this change. This change has no impact on our consolidated total revenues or total revenues by segment.


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended June 30,						Six Months Ended June 30,						Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended September 30,						Nine Months Ended September 30,
		2021			2020			2021			2020				2021			2020			2021			2020
Healthcare:	Healthcare:													Healthcare:
Revenues	Revenues	$	101,357		$	85,356		$	181,079		$	180,934		Revenues	$	92,845		$	87,406		$	273,924		$	268,340
Operating income	Operating income	$	27,624		$	21,171		$	48,108		$	45,221		Operating income	$	30,255		$	25,610		$	78,363		$	70,831
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	27.3		%	24.8		%	26.6		%	25.0		%	Segment operating income as a percentage of segment revenues	32.6		%	29.3		%	28.6		%	26.4		%
Business Advisory:	Business Advisory:													Business Advisory:
Revenues	Revenues	$	70,908		$	70,470		$	143,775		$	135,375		Revenues	$	69,966		$	66,048		$	213,741		$	201,423
Operating income	Operating income	$	14,315		$	16,684		$	27,392		$	26,526		Operating income	$	9,892		$	10,780		$	37,284		$	37,306
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	20.2		%	23.7		%	19.1		%	19.6		%	Segment operating income as a percentage of segment revenues	14.1		%	16.3		%	17.4		%	18.5		%
Education:	Education:													Education:
Revenues	Revenues	$	57,861		$	62,031		$	108,485		$	124,167		Revenues	$	61,196		$	51,850		$	169,681		$	176,017
Operating income	Operating income	$	13,770		$	16,128		$	22,423		$	29,244		Operating income	$	14,788		$	12,548		$	37,211		$	41,792
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues	23.8		%	26.0		%	20.7		%	23.6		%	Segment operating income as a percentage of segment revenues	24.2		%	24.2		%	21.9		%	23.7		%
Total Company:	Total Company:													Total Company:
Revenues	Revenues	$	230,126		$	217,857		$	433,339		$	440,476		Revenues	$	224,007		$	205,304		$	657,346		$	645,780
Reimbursable expenses	Reimbursable expenses	3,252			2,970			5,186			22,273			Reimbursable expenses	3,690			2,860			8,876			25,133
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses	$	233,378		$	220,827		$	438,525		$	462,749		Total revenues and reimbursable expenses	$	227,697		$	208,164		$	666,222		$	670,913
Statements of Operations reconciliation:	Statements of Operations reconciliation:													Statements of Operations reconciliation:
Segment operating income	Segment operating income	$	55,709		$	53,983		$	97,923		$	100,991		Segment operating income	$	54,935		$	48,938		$	152,858		$	149,929
Items not allocated at the segment level:	Items not allocated at the segment level:													Items not allocated at the segment level:
Other operating expenses	Other operating expenses	34,325			31,638			63,162			58,784			Other operating expenses	31,374			29,042			94,536			87,826
Litigation and other losses (gains)	Litigation and other losses (gains)	—			—			42			(150)			Litigation and other losses (gains)	56			—			98			(150)
Depreciation and amortization	Depreciation and amortization	5,255			6,391			10,350			12,438			Depreciation and amortization	5,199			6,197			15,549			18,635
Goodwill impairment charges (1)	Goodwill impairment charges (1)	—			—			—			59,816			Goodwill impairment charges (1)	—			—			—			59,816
Operating income (loss)	Operating income (loss)	16,129			15,954			24,369			(29,897)			Operating income (loss)	18,306			13,699			42,675			(16,198)
Other income (expense), net		122			1,032			(1,177)			(6,605)
Other expense, net														Other expense, net	(2,611)			(224)			(3,788)			(6,829)
Income (loss) from continuing operations before taxes	Income (loss) from continuing operations before taxes	16,251			16,986			23,192			(36,502)			Income (loss) from continuing operations before taxes	15,695			13,475			38,887			(23,027)
Income tax expense (benefit)	Income tax expense (benefit)	3,454			3,414			4,990			(7,801)			Income tax expense (benefit)	1,968			2,388			6,958			(5,413)
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	12,797		$	13,572		$	18,202		$	(28,701)		Net income (loss) from continuing operations	$	13,727		$	11,087		$	31,929		$	(17,614)
Earnings (loss) per share from continuing operations:	Earnings (loss) per share from continuing operations:													Earnings (loss) per share from continuing operations:
Basic	Basic	$	0.59		$	0.62		$	0.84		$	(1.31)		Basic	$	0.65		$	0.50		$	1.48		$	(0.81)
Diluted	Diluted	$	0.59		$	0.61		$	0.82		$	(1.31)		Diluted	$	0.64		$	0.50		$	1.46		$	(0.81)

2827

Table of Contents


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,						Nine Months Ended September 30,
Other Operating Data:	Other Operating Data:	2021			2020			2021			2020			Other Operating Data:	2021			2020			2021			2020
Number of billable consultants (at period end) (2):	Number of billable consultants (at period end) (2):													Number of billable consultants (at period end) (2):
Healthcare	Healthcare	779			855			779			855			Healthcare	849			838			849			838
Business Advisory	Business Advisory	1,093			943			1,093			943			Business Advisory	1,179			1,001			1,179			1,001
Education	Education	746			780			746			780			Education	816			790			816			790
Total	Total	2,618			2,578			2,618			2,578			Total	2,844			2,629			2,844			2,629
Average number of billable consultants (for the period) (2):	Average number of billable consultants (for the period) (2):													Average number of billable consultants (for the period) (2):
Healthcare	Healthcare	798			876			808			887			Healthcare	802			844			807			873
Business Advisory	Business Advisory	1,094			925			1,087			922			Business Advisory	1,136			976			1,103			940
Education	Education	736			787			734			782			Education	784			772			750			779
Total	Total	2,628			2,588			2,629			2,591			Total	2,722			2,592			2,660			2,592
Billable consultant utilization rate (3):	Billable consultant utilization rate (3):													Billable consultant utilization rate (3):
Healthcare	Healthcare	75.7		%	67.6		%	71.7		%	69.6		%	Healthcare	74.9		%	71.4		%	72.7		%	70.2		%
Business Advisory	Business Advisory	70.4		%	75.8		%	69.5		%	73.7		%	Business Advisory	69.0		%	72.6		%	69.3		%	72.6		%
Education	Education	75.2		%	73.4		%	72.7		%	74.8		%	Education	74.5		%	66.5		%	73.3		%	71.7		%
Total	Total	73.3		%	72.4		%	71.1		%	72.7		%	Total	72.2		%	70.4		%	71.5		%	71.5		%
Billable consultant average billing rate per hour (4):	Billable consultant average billing rate per hour (4):													Billable consultant average billing rate per hour (4):
Healthcare	Healthcare	$	251		$	208		$	233		$	212		Healthcare	$	229		$	232		$	232		$	218
Business Advisory (5)	Business Advisory (5)	$	185		$	201		$	194		$	199		Business Advisory (5)	$	184		$	186		$	191		$	197
Education	Education	$	189		$	191		$	182		$	189		Education	$	193		$	184		$	186		$	189
Total (5)	Total (5)	$	206		$	200		$	202		$	200		Total (5)	$	200		$	200		$	201		$	201
Revenue per billable consultant (in thousands):	Revenue per billable consultant (in thousands):													Revenue per billable consultant (in thousands):
Healthcare	Healthcare	$	84		$	63		$	147		$	132		Healthcare	$	74		$	71		$	221		$	203
Business Advisory	Business Advisory	$	60		$	73		$	125		$	140		Business Advisory	$	57		$	64		$	182		$	204
Education	Education	$	67		$	68		$	125		$	136		Education	$	65		$	57		$	191		$	194
Total	Total	$	69		$	68		$	132		$	136		Total	$	64		$	64		$	196		$	200
Average number of full-time equivalents (for the period) (6):	Average number of full-time equivalents (for the period) (6):													Average number of full-time equivalents (for the period) (6):
Healthcare	Healthcare	162			186			158			187			Healthcare	149			191			154			188
Business Advisory	Business Advisory	55			25			45			22			Business Advisory	59			35			50			27
Education	Education	40			60			38			60			Education	49			46			41			56
Total	Total	257			271			241			269			Total	257			272			245			271
Revenue per full-time equivalent (in thousands):	Revenue per full-time equivalent (in thousands):													Revenue per full-time equivalent (in thousands):
Healthcare	Healthcare	$	127		$	123		$	257		$	261		Healthcare	$	133		$	110		$	392		$	371
Business Advisory	Business Advisory	$	88		$	128		$	176		$	275		Business Advisory	$	93		$	106		$	270		$	370
Education	Education	$	214		$	147		$	441		$	292		Education	$	203		$	165		$	643		$	453
Total	Total	$	132		$	129		$	271		$	269		Total	$	137		$	119		$	410		$	388
Healthcare Managed Services Employees(7):
Healthcare Managed Services employees(7):														Healthcare Managed Services employees(7):
Total revenues (in thousands)	Total revenues (in thousands)	$	14,049		$	7,285		$	21,797		$	15,069		Total revenues (in thousands)	$	13,612		$	6,423		$	35,409		$	21,493
Average number of Healthcare Managed Services employees (for the period)	Average number of Healthcare Managed Services employees (for the period)	431			94			270			93			Average number of Healthcare Managed Services employees (for the period)	485			88			342			91

(1)The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance.

(2)Consists of our consulting professionals who provide consulting services and generate revenues based on the number of hours worked.

(3)Utilization rate for our billable consultants is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.

(4)Average billing rate per hour for our billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.

(5)The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been ~~$201~~$200 and ~~$220~~$201 for the three months ended ~~June~~September 30, 2021 and 2020, respectively; and ~~$211~~$207 and ~~$222~~$217 for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively.

2928

Table of Contents

Absent the impact of Huron Eurasia India, Huron's consolidated average billing rate per hour would have been ~~$213~~$207 and ~~$207~~$206 for the three months ended ~~June~~September 30, 2021 and 2020, respectively; and ~~$209 and~~ $208 for both the ~~six~~nine months ended ~~June~~September 30, 2021 and ~~2020, respectively.~~2020.

(6)Consists of coaches and their support staff within our Culture and Organizational Excellence solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

(7)Consists of employees who manage and provide revenue cycle billing, collections, insurance verification and change integrity services to our healthcare clients.

Non-GAAP Measures

We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure earnings before interest, taxes, depreciation and amortization ~~("EBITDA"~~(“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands, except per share amounts):


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,						Nine Months Ended September 30,
		2021			2020			2021			2020				2021			2020			2021			2020
Revenues	Revenues	$	230,126		$	217,857		$	433,339		$	440,476		Revenues	$	224,007		$	205,304		$	657,346		$	645,780
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	12,797		$	13,572		$	18,202		$	(28,701)		Net income (loss) from continuing operations	$	13,727		$	11,087		$	31,929		$	(17,614)
Add back:	Add back:													Add back:
Income tax expense (benefit)	Income tax expense (benefit)	3,454			3,414			4,990			(7,801)			Income tax expense (benefit)	1,968			2,388			6,958			(5,413)
Interest expense, net of interest income	Interest expense, net of interest income	2,029			2,916			3,748			5,257			Interest expense, net of interest income	2,217			2,259			5,965			7,516
Depreciation and amortization	Depreciation and amortization	6,555			7,527			13,106			14,942			Depreciation and amortization	6,534			7,546			19,640			22,488
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA)		24,835			27,429			40,046			(16,303)
Earnings before interest, taxes, depreciation and amortization (EBITDA)														Earnings before interest, taxes, depreciation and amortization (EBITDA)	24,446			23,280			64,492			6,977
Add back:	Add back:													Add back:
Restructuring and other charges	Restructuring and other charges	861			109			1,489			2,567			Restructuring and other charges	1,677			59			3,166			2,626
Litigation and other losses (gains)	Litigation and other losses (gains)	—			—			42			(150)			Litigation and other losses (gains)	56			—			98			(150)
Goodwill impairment charges	Goodwill impairment charges	—			—			—			59,816			Goodwill impairment charges	—			—			—			59,816
Loss on sale of business	Loss on sale of business	—			—			—			102			Loss on sale of business	—			—			—			102
Transaction-related expenses	Transaction-related expenses	(29)			—			141			—			Transaction-related expenses	194			437			335			437
Foreign currency transaction losses (gains), net	Foreign currency transaction losses (gains), net	(48)			(81)			355			439			Foreign currency transaction losses (gains), net	43			(194)			398			245
Adjusted EBITDA	Adjusted EBITDA	$	25,619		$	27,457		$	42,073		$	46,471		Adjusted EBITDA	$	26,416		$	23,582		$	68,489		$	70,053
Adjusted EBITDA as a percentage of revenues	Adjusted EBITDA as a percentage of revenues	11.1		%	12.6		%	9.7		%	10.6		%	Adjusted EBITDA as a percentage of revenues	11.8		%	11.5		%	10.4		%	10.8		%

3029

Table of Contents


		Three Months Ended June 30,				Six Months Ended June 30,					Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020			2021		2020		2021		2020
Net income (loss) from continuing operations	Net income (loss) from continuing operations	$	12,797	$	13,572	$	18,202	$	(28,701)	Net income (loss) from continuing operations	$	13,727	$	11,087	$	31,929	$	(17,614)
Weighted average shares - diluted	Weighted average shares - diluted	21,871		22,116		22,105		21,848		Weighted average shares - diluted	21,531		22,175		21,904		21,868
Diluted earnings (loss) per share from continuing operations	Diluted earnings (loss) per share from continuing operations	$	0.59	$	0.61	$	0.82	$	(1.31)	Diluted earnings (loss) per share from continuing operations	$	0.64	$	0.50	$	1.46	$	(0.81)
Add back:	Add back:									Add back:
Amortization of intangible assets	Amortization of intangible assets	2,289		3,194		4,688		6,403		Amortization of intangible assets	2,235		3,155		6,923		9,558
Restructuring and other charges	Restructuring and other charges	861		109		1,489		2,567		Restructuring and other charges	1,677		59		3,166		2,626
Litigation and other losses (gains)	Litigation and other losses (gains)	—		—		42		(150)		Litigation and other losses (gains)	56		—		98		(150)
Goodwill impairment charges	Goodwill impairment charges	—		—		—		59,816		Goodwill impairment charges	—		—		—		59,816
Loss on sale of business	Loss on sale of business	—		—		—		102		Loss on sale of business	—		—		—		102
Transaction-related expenses	Transaction-related expenses	(29)		—		141		—		Transaction-related expenses	194		437		335		437
Tax effect of adjustments	Tax effect of adjustments	(827)		(1,940)		(1,685)		(15,349)		Tax effect of adjustments	(1,103)		(1,692)		(2,788)		(17,041)

Total adjustments, net of tax	Total adjustments, net of tax	2,294		1,363		4,675		53,389		Total adjustments, net of tax	3,059		1,959		7,734		55,348
Adjusted net income from continuing operations	Adjusted net income from continuing operations	$	15,091	$	14,935	$	22,877	$	24,688	Adjusted net income from continuing operations	$	16,786	$	13,046	$	39,663	$	37,734
Adjusted weighted average shares - diluted	Adjusted weighted average shares - diluted	21,871		22,116		22,105		22,223		Adjusted weighted average shares - diluted	21,531		22,175		21,904		22,207
Adjusted diluted earnings per share from continuing operations	Adjusted diluted earnings per share from continuing operations	$	0.69	$	0.68	$	1.03	$	1.11	Adjusted diluted earnings per share from continuing operations	$	0.78	$	0.59	$	1.81	$	1.70

These non-GAAP financial measures include adjustments for the following items:

Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the calculation of adjusted net income from continuing operations presented above. Amortization of intangible assets is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

Restructuring and other charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and severance charges. Additionally, we have excluded the effect of a $0.8 million one-time charge incurred during the first quarter of 2020, related to redundant administrative costs in our corporate operations which is recorded within selling, general and administrative expenses on our consolidated statement of operations. We have excluded the effect of the restructuring and other charges from our non-GAAP measures to permit comparability with periods that were not impacted by these items.

Litigation and other losses (gains): We have excluded the effect of a loss in the first and third quarter of 2021 from an increase in the estimated fair value of our liability for contingent consideration ~~payments~~ related to a business acquisition and a litigation settlement gain recognized in the first quarter of 2020 to permit comparability with periods that were not impacted by these items.

Goodwill impairment charges: We have excluded the effect of the goodwill impairment charges recognized in the first quarter of 2020 as these charges are infrequent events and their exclusion permits comparability with periods that were not impacted by such charges.

Loss on sale of business: We excluded the effect of the loss on sale of a software-based solution within our Business Advisory segment in the first quarter of 2020. Divestitures of businesses are infrequent and are not indicative of the ongoing performance of our business.

Transaction-related expenses: To permit comparability with prior periods, we excluded the impact of third-party legal and accounting fees incurred in the first ~~and second quarters~~nine months of 2021 and 2020 related to ~~the acquisition of Unico Solution, Inc. and ForceIQ, Inc., which closed effective February 1, 2021 and November 1, 2020, respectively.~~business acquisitions.

Foreign currency transaction losses (gains), net: We have excluded the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.

Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.

Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We have excluded the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA, as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items. Included within the depreciation and amortization adjustment is the amortization of capitalized implementation costs of our ERP and other related software, which is included within ~~Selling,~~selling, general and administrative expenses on our consolidated statement of operations.

Adjusted weighted average shares - diluted: As we reported a net loss for the first ~~six~~nine months of 2020, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. The non-GAAP adjustments described above resulted in adjusted net income from continuing operations for the first ~~six~~nine months of 2020. Therefore, we included the dilutive common stock equivalents in the calculation of adjusted diluted weighted average shares outstanding for that period.

3130

Table of Contents

Three Months Ended ~~June~~September 30, 2021 Compared to Three Months Ended ~~June~~September 30, 2020

Revenues

Revenues increased ~~$12.3~~$18.7 million, or ~~5.6%~~9.1%, to ~~$230.1~~$224.0 million for the ~~second~~third quarter of 2021 from ~~$217.9~~$205.3 million for the ~~second~~third quarter of 2020. The increase in revenues ~~is primarily related to~~reflects strengthened demand for services in all of our ~~Healthcare and Business Advisory~~ segments, as well as the favorable comparison against results for the ~~second~~third quarter of 2020 ~~for the~~in our Healthcare ~~segment,~~and Education segments which ~~was~~were more significantly impacted by the COVID-19 pandemic as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic.The increase in revenues is partially offset by a decrease in demand for services in our Education segment during the second quarter of 2021 compared to the second quarter of 2020 as Education segment revenues were not significantly impacted by the COVID-19 pandemic until the second half of 2020.pandemic.

Of the ~~$12.3~~$18.7 million increase in revenues, ~~$6.8~~$8.6 million was attributable to an increase in revenues generated by our billable consultants, $7.2 million was attributable to an increase in revenues generated by our Healthcare Managed Services employees, and ~~$6.4~~$2.9 million was attributable to ~~an increase in revenues generated by our billable consultants, partially offset by a $0.9 million decrease in~~ revenues generated by our full-time equivalents.

The increase in billable consultant revenues reflected strengthened demand for services in our Education and Business Advisory segments, partially offset by a decrease in demand for certain services in our Healthcare segment, as discussed below in Segment Results. The overall increase in billable consultant revenues was primarily attributable to overall increases in the average number of billable consultants and the consultant utilization rate for the third quarter of 2021 compared to the same prior year period.

The increase in Healthcare Managed Services revenues was primarily attributable to an increase in demand for these services, which led to an increase in the average number of managed services employees in the ~~second~~third quarter of 2021 compared to the same prior year period. InAt the beginning of the second quarter of 2021, we hired approximately 300 employees to expand our capacity to manage and provide revenue cycle billing, collections, insurance verification and change integrity services to our healthcare clients. These employees are serving new and existing clients in our Healthcare Managed Services solution, including serving under a short-term contract with an existing client which we entered into in connection with this group hire.

The increase in ~~billable consultant~~full-time equivalent revenues ~~reflected strengthened demand for services~~was primarily attributable to an increase in ~~our Healthcare segment, partially offset by decreases in demand for services~~full-time equivalent revenues in our Education and Business Advisory segments, as discussed below in Segment Results. The overall increase in billable consultant revenues was primarily attributable to overall increases in the average billing rate, the average number of billable consultants, and the consultant utilization rate for the second quarter of 2021 compared to the same prior year period.

The decrease in full-time equivalent revenues was primarily attributable to a decrease in full-time equivalent revenues in our Healthcare segment, partially offset by an increase in full-time equivalent revenues in our Business Advisory segment, as discussed below in Segment Results. The overall decrease in full-time equivalent revenues reflected an overall increase in revenue per full-time equivalent, partially offset by an overall decrease in the average number of full-time equivalents ~~partially offset by an overall increase in revenue per full-time equivalent~~ in the ~~second~~third quarter of 2021 compared to the same prior year period.

In most of 2020 and the first quarter of 2021, the COVID-19 pandemic negatively impacted sales and elongated the sales cycle for new opportunities for certain services, particularly within our Healthcare and Education segments as some clients reprioritized or delayed certain projects. During the ~~first half~~second and third quarters of 2021, we saw an increase in our sales pipeline and the pace of signings in our Healthcare and Education businesses. As the overall demand for our services ~~strengthened~~continued to strengthen in the second ~~quarter~~and third quarters of 2021, we expect continued revenue growth in the ~~second half~~fourth quarter of 2021 compared to the ~~second half~~fourth quarter of 2020.

Total Direct Costs

Direct costs, excluding amortization of intangible assets and software development costs, increased ~~$12.0~~$8.4 million, or ~~8.0%~~5.8%, to ~~$161.5~~$153.9 million for the three months ended ~~June~~September 30, 2021, from ~~$149.5~~$145.5 million for the three months ended ~~June~~September 30, 2020. The ~~$12.0~~$8.4 million increase primarily related to ~~an $9.2~~a $9.8 million increase in salaries and related expenses for our revenue-generating professionals, a ~~$1.8~~$1.0 million increase in signing, retention and other bonus expense for our revenue-generating professionals, ~~and~~ a ~~$1.7~~$0.9 million increase in ~~performance bonus~~share-based compensation expense for our revenue-generating ~~professionals.~~professionals, a $0.7 million increase in contractor expense and a $0.5 million increase in product and event costs. These increases in direct costs were partially offset by a ~~$1.0~~$4.5 million decrease in ~~contractor expense.~~performance bonus expense for our revenue-generating professionals which primarily reflects a decrease in the performance bonus adjustment recorded in the third quarter of 2021 compared to the third quarter of 2020 to adjust our year-to-date performance bonus accrual to reflect the revised full year forecasts. As a percentage of revenues, direct costs ~~increased~~decreased to ~~70.2%~~68.7% during the ~~second~~third quarter of 2021 compared to ~~68.6%~~70.9% during the ~~second~~third quarter of 2020, primarily due to the decrease in performance bonus expense for our revenue-generating professionals, partially offset by the increases in ~~salaries and related expenses and~~ signing, retention and other bonus expense and share-based compensation expense for our revenue-generating professionals, as percentages of ~~revenues, partially offset by the decrease in contractor expense.~~revenues.

Total direct costs for the three months ended ~~June~~September 30, 2021 included $0.9 million of amortization expense for internal software development costs and intangible assets, compared to ~~$1.3~~$1.4 million of amortization expense for the same prior year period. Intangible asset amortization included within direct costs for the three months ended ~~June~~September 30, 2021 and 2020 primarily related to technology and software, certain customer relationships and customer contracts acquired in connection with our business acquisitions. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on our intangible assets.

Operating Expenses and Other Losses (Gains), Net

Selling, general and administrative expenses increased by ~~$0.3~~$5.0 million, or ~~0.7%~~12.9%, to ~~$45.2~~$43.5 million in the ~~second~~third quarter of 2021 from ~~$44.9~~$38.6 million in the ~~second~~third quarter of 2020. The overall ~~$0.3~~$5.0 million increase primarily related to a ~~$1.0~~$1.4 million increase in ~~legal expenses, a $0.9 million increase in performance bonus~~share-based compensation expense for our support personnel, a $1.2 million increase in promotion and marketing expense, a ~~$0.6~~$1.1 million increase in salaries and related expenses for our support personnel, a $0.8 million increase in software and data hosting ~~expenses.~~expense, a $0.6 million increase in signing, retention and other bonus

Table of Contents

expense for our support personnel, a $0.6 million increase in research expense, a $0.6 million increase in legal expenses, a $0.5 million increase in practice administration and meetings expense, and a $0.5 million increase in third-party consulting expense. The increase in share-based compensation expense primarily related to a decrease in the expected funding of performance-based share awards for our executive officers recorded in the third quarter of 2020. These increases were ~~largely~~partially offset by a ~~$1.8~~$2.2 million decrease in deferred compensation expense attributable to the change in the market value of our deferred compensation liability, and a ~~$0.7~~$1.2 million decrease in ~~share-based compensation~~performance bonus expense for our support personnel. During the ~~second~~third quarter of

~~Table of Contents~~

2021, the market value of our deferred compensation liability ~~increased~~decreased by ~~$2.1~~$0.4 million, compared to ~~a $3.9~~an increase of $1.8 million ~~increase~~ in the ~~second~~third quarter of 2020. This ~~$1.8~~$2.2 million decrease in expense is offset by a ~~$1.8~~$2.2 million decrease in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income (expense), net. The decrease in share-based compensation expense primarily related to a decrease in the expected funding of performance-based share awards for our executive officers recorded in the first quarter of 2021. As a percentage of revenues, selling, general and administrative expenses ~~decreased~~increased to ~~19.6%~~19.4% during the ~~second~~third quarter of 2021 compared to ~~20.6%~~18.8% during the ~~second~~third quarter of 2020. This ~~decrease~~increase was primarily attributable to the ~~decrease~~increases in selling, general and administrative expenses described above, as percentages of revenues, partially offset by the decreases in deferred compensation ~~expense.~~expense and performance bonus expense for our support personnel.

Restructuring charges for the ~~second~~third quarter of 2021 were ~~$0.9~~$1.7 million, compared to $0.1 million for the ~~second~~third quarter of 2020. The ~~$0.9~~$1.7 million of restructuring charges recognized in the ~~second~~third quarter of 2021 consisted of $0.7 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business within our Business Advisory segment, $0.5 million of rent and related expenses, net of sublease income, for previously vacated office spaces, and $0.5 million of employee-related expenses. The $0.1 million of restructuring charges recognized in the third quarter of 2020 primarily related to rent and related expenses, net of sublease income, for vacated office spaces. See Note 8 ~~"Restructuring Charges"~~“Restructuring Charges” within the notes to our consolidated financial statements for additional information on our restructuring charges.

Depreciation and amortization expense decreased ~~$0.7~~$0.8 million, or ~~12.1%~~12.4%, to $5.4 million for the three months ended ~~June~~September 30, 2021 compared to $6.2 million for the three months ended ~~June~~September 30, 2020. The ~~$0.7~~$0.8 million decrease in depreciation and amortization expense was primarily attributable to decreasing amortization expense for customer relationships acquired in business acquisitions due to the accelerated basis of amortization in prior periods, including the customer relationships acquired in our Studer Group acquisition; and customer relationships acquired in other business acquisitions that were fully amortized in prior periods; as well as a decrease in depreciation expense for leasehold improvements and furniture and fixtures related to vacated office spaces. Intangible asset amortization expense included within operating expenses primarily related to certain customer relationships, trade names, and non-competition agreements acquired in connection with our business acquisitions. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on our intangible assets.

Operating Income

Operating income increased ~~$0.2~~$4.6 million to ~~$16.1~~$18.3 million in the ~~second~~third quarter of 2021 from ~~$16.0~~$13.7 million in the ~~second~~third quarter of ~~2020 as the increase in revenues was largely offset by the increases in direct costs and selling, general and administrative expenses previously discussed.~~2020. Operating margin, which is defined as operating income expressed as a percentage of revenues, was ~~7.0%~~8.2% for the three months ended ~~June~~September 30, 2021 compared to ~~7.3%~~6.7% for the three months ended ~~June~~September 30, 2020. The ~~decrease~~increase in operating margin was primarily attributable to the ~~increases~~increase in ~~salaries~~revenues and ~~related expenses for our revenue-generating professionals and signing, retention and other~~the decreases in performance bonus expense for our revenue-generating professionals, deferred compensation expense, performance bonus expense for our support personnel, and depreciation and amortization expense, partially offset by the ~~decrease~~increases in ~~deferred~~share-based compensation expense ~~attributable to the change in the market value~~for our support personnel and restructuring charges, as percentages of ~~our deferred compensation liability and the decrease in contractor expense.~~revenues.

Total Other Income (Expense), Net

Interest expense, net of interest income decreased ~~$0.9~~less than $0.1 million to ~~$2.0~~$2.2 million in the ~~second~~third quarter of 2021 from ~~$2.9~~$2.3 million in the ~~second~~third quarter of 2020. ~~The decrease in interest expense was primarily attributable to lower levels of borrowing under our credit facility during the second quarter of 2021 compared to the same prior year period.~~ See Note 7 ~~"Financing Arrangements"~~“Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.

Other income (expense), net decreased ~~$1.8~~$2.4 million to ~~$2.2~~other expense, net of $0.4 million in the ~~second~~third quarter of 2021 from ~~$3.9~~other income, net of $2.0 million in the ~~second~~third quarter of 2020. The decrease in other income, net was primarily attributable to the ~~$1.8~~$2.2 million decrease in the gain recognized for the market value of our investments that are used to fund our deferred compensation liability. During the ~~second~~third quarter of 2021, we recognized a ~~$2.1~~$0.4 million ~~gain~~loss for the market value of our deferred compensation investments compared to a ~~$3.9~~$1.8 million gain recognized in the ~~second~~third quarter of 2020.

Income Tax Expense

For the three months ended ~~June~~September 30, 2021, our effective tax rate was ~~21.3%~~12.5% as we recognized income tax expense from continuing operations of ~~$3.5~~$2.0 million on income from continuing operations of ~~$16.3~~$15.7 million. The effective tax rate of ~~21.3%~~12.5% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for U.S. federal return to provision adjustments related to ~~electing~~ the ~~Global Intangible Low-Taxed Income ("GILTI") high-tax exclusion retroactively for the 2018~~2020 corporate income tax year. On July 20, 2020, the U.S. Treasury issued and enacted final regulations related to GILTI that allow certain U.S. taxpayers to elect to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. The GILTI high-tax exclusion is an annual election and is retroactively available. This favorable item was partially offset by certain nondeductible expense items.return.

For the three months ended ~~June~~September 30, 2020, our effective tax rate was ~~20.1%~~17.7% as we recognized income tax expense from continuing operations of ~~$3.4~~$2.4 million on income from continuing operations of ~~$17.0~~$13.5 million. The effective tax rate of ~~20.1%~~17.7% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to the year-to-date pre-tax losses and the impact during the quarter of certain nondeductible expense items, including the nondeductible portion of the goodwill impairment charges, based on the attribution of those expenses to the quarter in

Table of Contents

accordance with the allocation of income tax expense on a ~~current~~ year-to-date basis. The effective tax rate also reflected the positive impact of certain federal tax credits. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on the goodwill impairment charges recognized in the first quarter of 2020.

~~Table of Contents~~

See Note 12 ~~"Income Taxes"~~“Income Taxes” within the notes to our consolidated financial statements for additional information on our income tax expense.

Net Income from Continuing Operations and Earnings per Share

Net income from continuing operations ~~decreased $0.8~~increased $2.6 million to ~~$12.8~~$13.7 million for the three months ended ~~June~~September 30, 2021 from ~~$13.6~~$11.1 million for the same period last year. As a result of the decrease in net income from continuing operations, diluted earnings per share from continuing operations for the ~~second~~third quarter of 2021 was ~~$0.59~~$0.64 compared to ~~$0.61~~$0.50 for the ~~second~~third quarter of 2020.

EBITDA and Adjusted EBITDA

EBITDA ~~decreased $2.6~~increased $1.2 million to ~~$24.8~~$24.4 million for the three months ended ~~June~~September 30, 2021 from ~~$27.4~~$23.3 million for the three months ended ~~June~~September 30, 2020. Adjusted EBITDA ~~decreased $1.8~~increased $2.8 million to ~~$25.6~~$26.4 million in the ~~second~~third quarter of 2021 from ~~$27.5~~$23.6 million in the ~~second~~third quarter of 2020. The ~~decrease~~increase in EBITDA was primarily attributable to an overall increase in ~~corporate expenses~~segment operating income, partially offset by an increase in ~~segment operating income.~~corporate expenses. The ~~decrease~~increase in adjusted EBITDA was primarily attributable to an increase in segment operating income, partially offset by an increase in corporate expenses, excluding the change in the market value of our deferred compensation liability for the third quarter of 2021 compared to the third quarter of 2020 and restructuring charges not allocated at the segment ~~level, partially offset by an increase in segment operating income.~~level. See ~~"Segment Results"~~Segment Results below for additional information on segment operating income.

Adjusted Net Income from Continuing Operations and Adjusted Earnings per Share

Adjusted net income from continuing operations increased ~~$0.2~~$3.7 million to ~~$15.1~~$16.8 million in the ~~second~~third quarter of 2021 compared to ~~$14.9~~$13.0 million in the ~~second~~third quarter of 2020. As a result of the increase in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations was ~~$0.69~~$0.78 for the ~~second~~third quarter of 2021, compared to ~~$0.68~~$0.59 for the ~~second~~third quarter of 2020.

Segment Results

Healthcare

Revenues

Healthcare segment revenues increased ~~$16.0~~$5.4 million, or ~~18.7%~~6.2%, to ~~$101.4~~$92.8 million for the ~~second~~third quarter of 2021 from ~~$85.4~~$87.4 million for the ~~second~~third quarter of 2020 due to strengthened demand for services in this segment in the ~~second~~third quarter of 2021, as well as the favorable comparison against results for the ~~second~~third quarter of 2020 which was ~~more~~ significantly impacted by the COVID-19 pandemic as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic.

During the three months ended ~~June~~September 30, 2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~54.3%~~61.2%, ~~17.8%~~19.2%, ~~22.8%~~13.7%, and ~~5.1%~~5.9% of this segment’s revenues, respectively, compared to ~~59.5%~~58.9%, ~~16.4%~~16.7%, ~~17.0%~~17.9%, and ~~7.1%~~6.5% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was ~~$23.1~~$12.7 million for the ~~second~~third quarter of 2021 compared to ~~$14.5~~$15.6 million for the ~~second~~third quarter of 2020. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

Of the overall ~~$16.0~~$5.4 million increase in revenues, ~~$11.5 million was attributable to an increase in revenues from our billable consultants and $6.8~~$7.2 million was attributable to an increase in revenues from our Healthcare Managed Services employees, partially offset by a ~~$2.3~~$1.2 million decrease in revenues from our full-time ~~equivalents.~~

~~The increase~~equivalents and a $0.6 million decrease in revenues ~~attributable to~~from our billable consultants reflected increases in the average billing rate and the consultant utilization rate, partially offset by a decrease in the average number of billable consultants in the second quarter of 2021 compared to the same prior year period. consultants.

The decrease in revenues from our full-time equivalents was primarily driven by a decrease in demand for certain services and a decreased use of contractors and project consultants; and reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the ~~second~~third quarter of 2021 compared to the same prior year period.

The decrease in revenues attributable to our billable consultants reflected decreases in the average number of billable consultants and the average billing rate, partially offset by an increase in the consultant utilization rate in the third quarter of 2021 compared to the same prior year period.

3433

Table of Contents

Operating Income

Healthcare segment operating income increased ~~$6.5~~$4.6 million, or ~~30.5%~~18.1%, to ~~$27.6~~$30.3 million for the three months ended ~~June~~September 30, 2021 from ~~$21.2~~$25.6 million for the three months ended ~~June~~September 30, 2020. The Healthcare segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, increased to ~~27.3%~~32.6% for the ~~second~~third quarter of 2021 from ~~24.8%~~29.3% in the same period last year. The increase in this segment’s operating margin was primarily attributable to ~~revenue growth that outpaced an increase~~a decrease in ~~salaries and related expenses~~performance bonus expense for our revenue-generating professionals as well as ~~decreases~~a decrease in salaries and related expenses for our support ~~personnel, contractor expense, technology expenses, and amortization of intangible assets included in direct costs.~~personnel. These increases to the operating margin were partially offset by increases in ~~performance bonus expense for our revenue-generating professionals and~~ signing, retention and other bonus expense for our revenue-generating professionals and product and event costs, as percentages of revenues.

Business Advisory

Revenues

Business Advisory segment revenues increased ~~$0.4~~$3.9 million, or ~~0.6%~~5.9%, to ~~$70.9~~$70.0 million for the ~~second~~third quarter of 2021 from ~~$70.5~~$66.0 million for the ~~second~~third quarter of 2020, primarily related to strengthened demand for our strategy and innovation solutions and our cloud-based technology and analytics ~~solutions and our strategy and innovation~~ solutions. Revenues for the ~~second~~third quarter of 2021 included ~~$4.3~~$4.5 million from our acquisitions of ForceIQ and Unico Solutions, which were completed in November 2020 and February 2021, respectively.

During the three months ended ~~June~~September 30, 2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~44.2%~~44.0%, ~~50.8%~~50.4%, ~~2.1%~~2.3%, and ~~2.9%~~3.3% of this segment’s revenues, respectively, compared to ~~38.8%~~31.3%, ~~57.1%~~61.3%, ~~2.3%~~5.6%, and 1.8% of this segment's revenues, respectively, for the same prior year period. Performance-based fee revenue was ~~$1.5~~$1.6 million for the ~~second~~third quarter of 2021 compared to ~~$1.6~~$3.7 million for the ~~second~~third quarter of 2020. The level of performance-based fees earned may vary based on our clients’ preferences, the mix of services we provide, and the timing of transactions or milestones.

Of the overall ~~$0.4~~$3.9 million increase in revenues, ~~$1.6~~$2.1 million was attributable to an increase in revenues from our billable consultants and $1.8 million was attributable to an increase in revenues from our full-time ~~equivalents, partially offset by a $1.2 million decrease~~equivalents. The increase in revenues from our billable ~~consultants.~~consultants reflected an increase in the average number of billable consultants, partially offset by decreases in the consultant utilization rate and the average billing rate in the third quarter of 2021 compared to the same prior year period. The increase in revenues generated by our full-time equivalents was primarily driven by an increased use of contractors and project consultants; and reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the second quarter of 2021 compared to the same prior year period. The decrease in revenues from our billable consultants reflected decreases in the average billing rate and the consultant utilization rate, partially offset by an increase in the average number of billable consultants in the secondthird quarter of 2021 compared to the same prior year period.

On November 1, 2021, we completed the divestiture of the Life Sciences business to Oliver Wyman. The Life Sciences business, a reporting unit within the Business Advisory segment, provides commercial and research and development strategy, pricing and market access strategy solutions to customers in the life sciences industries. For the three months ended September 30, 2021, Life Sciences revenues were $5.1 million. The Life Sciences business is not significant to our consolidated financial statements and does not qualify as a discontinued operation for reporting under GAAP.

Operating Income

Business Advisory segment operating income decreased by ~~$2.4~~$0.9 million, or ~~14.2%~~8.2%, to ~~$14.3~~$9.9 million for the three months ended ~~June~~September 30, 2021 from ~~$16.7~~$10.8 million for the three months ended ~~June~~September 30, 2020. The Business Advisory segment operating margin decreased to ~~20.2%~~14.1% for the ~~second~~third quarter of 2021 from ~~23.7%~~16.3% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries and related expenses for our revenue-generating professionals and contractor expense, as percentages of revenues, as well as increases in restructuring charges, promotion and marketing expense and practice administration and meetings expense, as percentages of revenues. These decreases to the segment's operating margin were partially offset by a decrease in performance bonus expense for our revenue-generating professionals.

Education

Revenues

Education segment revenues ~~decreased $4.2~~increased $9.3 million, or ~~6.7%~~18.0%, to ~~$57.9~~$61.2 million for the ~~second~~third quarter of 2021 from ~~$62.0~~$51.9 million for the ~~second~~third quarter of ~~2020. The decrease~~2020 due to strengthened demand for services in ~~revenues~~this segment in the third quarter of 2021, as well as the favorable comparison against results for the third quarter of 2020 which was ~~related to the continued negative impact of~~significantly impacted by the COVID-19 pandemic ~~on demand for this segment's services~~ as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic beginning in the second half of 2020, and is also reflective of the difficult second quarter comparison driven by the strong growth we experienced in this segment in the first half of 2020 prior to the impact of the pandemic on this segment.pandemic.

During the three months ended ~~June~~September 30, 2021, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented ~~30.9%~~24.5%, ~~57.1%~~63.4%, and ~~12.0%~~12.1% of this segment’s revenues, respectively. During the three months ended June 30, 2020, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 18.4%respectively, compared to 21.1%, ~~71.8%, 1.1%~~67.9%, and ~~8.7%~~11.0% of this segment’s revenues, ~~respectively.~~

Of the overall $4.2 million decrease in revenues, $3.9 million was attributable to a decrease in revenues from our billable consultants and $0.3 million was attributable to a decrease in revenues from our full-time equivalents. The decrease in revenues attributable to our billable consultants reflected decreases in the average number of billable consultants and the average billing rate, partially offset by an increase in the consultant utilization rate in the second quarter of 2021 compared to the same prior year period. The decrease in revenues from our full-time equivalents was primarily driven by a decreased use of contractors and project consultants, partially offset by an increase in software subscriptions, software support and maintenance, and data hosting revenues. The overall decrease in full-time equivalent revenues reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the second quarter of 2021 compared torespectively, for the same prior year period.

3534

Table of Contents

Of the overall $9.3 million increase in revenues, $7.0 million was attributable to an increase in revenues from our billable consultants and $2.3 million was attributable to an increase in revenues from our full-time equivalents. The increase in revenues attributable to our billable consultants reflected increases in the consultant utilization rate, the average billing rate, and the average number of billable consultants in the third quarter of 2021 compared to the same prior year period. The increase in revenues from our full-time equivalents was primarily driven by an increase in software subscriptions and data hosting revenues, and reflected increases in revenue per full-time equivalent and the average number of full-time equivalents in the third quarter of 2021 compared to the same prior year period.

Operating Income

Education segment operating income ~~decreased $2.4~~increased $2.2 million, or ~~14.6%~~17.9% to ~~$13.8~~$14.8 million for the three months ended ~~June~~September 30, 2021 from ~~$16.1~~$12.5 million for the three months ended ~~June~~September 30, 2020. The Education segment operating margin ~~decreased to 23.8%~~was 24.2% for both the ~~second~~third quarter of 2021 ~~from 26.0% in~~and 2020. This segment's revenue growth outpaced the ~~same period last year. The decrease in this segment’s operating margin was primarily attributable to an~~ increase in salaries and related expenses for our revenue-generating ~~professionals as a percentage of revenues and~~professionals. This increase to the segment's operating margin was largely offset by increases in performance bonus expense ~~for our revenue-generating professionals, signing, retention~~ and ~~other bonus~~share-based compensation expense for our revenue-generating professionals, ~~and technology expenses. These decreases to the operating margin were partially offset by decreases in contractor expense and promotion and marketing expenses,~~ as percentages of revenues.

~~Six~~Nine Months Ended ~~June~~September 30, 2021 Compared to ~~Six~~Nine Months Ended ~~June~~September 30, 2020

Revenues

Revenues ~~decreased $7.1~~increased $11.6 million, or ~~1.6%~~1.8%, to ~~$433.3~~$657.3 million for the first ~~six~~nine months of 2021 from ~~$440.5~~$645.8 million for the first ~~six~~nine months of 2020. ~~Revenues~~The increase in the first half of 2021, and particularly in the first quarter of 2021, were negatively impacted by the COVID-19 pandemic as some clients reprioritized and delayed projects, specifically in our Healthcare and Education segments. However, in the second quarter of 2021, we sawrevenues reflects strengthened demand for ~~certain of our~~ services ~~within the Healthcare and Business Advisory segments, which partially offset the overall decrease in revenues in the first six months of 2021 compared to the first six months of 2020.~~

Of the overall $7.1 million decrease in revenues, $7.1 million was attributable to a decrease in revenues from our full-time equivalents and $6.7 million was attributable to a decrease in revenues from our our billable consultants, partially offset by a $6.7 million increase in revenues from our Healthcare Managed Services employees.

The decrease in full-time equivalent revenues was primarily attributable to decreases in full-time equivalent revenues in our Healthcare segment, partially offset by an increase in full-time equivalent revenues in our Business Advisory ~~segment, as discussed below in Segment Results;~~ and ~~reflected an overall decrease in the average number of full-time equivalents,~~Healthcare segments, partially offset by ~~an overall increase in revenue per full-time equivalent during the first six months of 2021 compared to the first six months of 2020.~~

~~The decrease in billable consultant revenues was attributable to~~ a decrease in demand for services in our Education segment, ~~partially offset by an increase in demand for services in our Business Advisory and Healthcare segments,~~ as discussed below in Segment Results. ~~The~~

Of the overall ~~decrease~~$11.6 million increase in revenues, $13.9 million was attributable to an increase in revenues from our Healthcare Managed Services employees and $2.0 million was attributable to an increase in revenues from our billable ~~consultant revenues reflected an overall decrease in the consultant utilization rate,~~consultants, partially offset by ~~overall increases~~a $4.3 million decrease in ~~the average number of billable consultants and the average billing rate during the first six months of 2021 compared to the same prior year period.~~revenues from our full-time equivalents.

The increase in Healthcare Managed Services revenues was primarily attributable to an increase in demand for these services, which led to an increase in the average number of Healthcare Managed Services employees in the first ~~half~~nine months of 2021 compared to the same prior year ~~period driven by the hiring of approximately 300 employees in~~period. At the beginning of the second quarter of 2021, we hired approximately 300 employees to expand our capacity to manage and provide revenue cycle billing, collections, insurance verification and change integrity services to our healthcare clients. These employees are serving new and existing clients in our Healthcare Managed Services solution, including serving under a short-term contract with an existing client which we entered into in connection with this group hire.

The increase in billable consultant revenues was attributable to an increase in demand for services in our Business Advisory segment, largely offset by a decrease in demand for services in our Education segment, as discussed below in Segment Results. The overall increase in billable consultant revenues reflected an overall increase in the average number of billable consultants during the first nine months of 2021 compared to the same prior year period.

The decrease in full-time equivalent revenues was primarily attributable to a decrease in full-time equivalent revenues in our Healthcare segment, partially offset by increases in full-time equivalent revenues in our Business Advisory and Education segments, as discussed below in Segment Results; and reflected an overall decrease in the average number of full-time equivalents, partially offset by an overall increase in revenue per full-time equivalent during the first nine months of 2021 compared to the first nine months of 2020.

In most of 2020 and the first quarter of 2021, the COVID-19 pandemic negatively impacted sales and elongated the sales cycle for new opportunities for certain services, particularly within our Healthcare and Education segments as some clients reprioritized or delayed certain projects. During the ~~first half~~second and third quarters of 2021, we saw an increase in our sales pipeline and the pace of signings in our Healthcare and Education businesses. While overall demand for our services in the first quarter of 2021 was negatively impacted by the COVID-19 pandemic, the overall demand for our services strengthened in the second ~~quarter~~and third quarters of 2021 and we expect continued revenue growth in the ~~second half~~fourth quarter of 2021 compared to the ~~second half~~fourth quarter of 2020.

The COVID-19 pandemic has caused the need for many companies to accelerate their digital transformation to drive operational efficiencies, better engage with their customers, and make better data-driven decisions. This has resulted in strong demand for our digital, technology and analytic offerings, particularly within our Business Advisory segment. Indicative of our expectations for future growth in this segment, we continue to make investments in these offerings, both organically and through strategic acquisitions, such as our acquisitions of ForceIQ in November 2020 and Unico Solutions in February 2021, and through the addition of new offerings and capabilities within this segment where we see strategic opportunities.

Total Direct Costs

Direct costs, excluding amortization of intangible assets and software development costs, increased ~~$3.9~~$12.3 million, or ~~1.3%~~2.7%, to ~~$309.6~~$463.5 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from ~~$305.8~~$451.2 million for the ~~six~~nine months ended ~~June~~September 30, 2020. The overall ~~$3.9~~$12.3 million increase primarily related to a ~~$6.3~~$16.1 million increase in salaries and related expenses for our revenue-generating professionals and a ~~$1.4~~$2.4 million increase in

Table of Contents

signing, retention and other bonus expense for our revenue-generating professionals, partially offset by a ~~$2.6~~$4.2 million decrease in performance bonus expense for our revenue-generating professionals and a $1.8 million decrease in contractor ~~expense and a $1.1 million decrease in share-based compensation expense for our revenue-generating professionals.~~expense. As a percentage of revenues, our direct costs increased to ~~71.5%~~70.5% during the first ~~six~~nine months of 2021 compared to ~~69.4%~~69.9% during the first ~~six~~nine months of 2020 primarily due to the increase in salaries and related expenses for our revenue-generating professionals, as a percentage of revenues, partially offset by the decrease in ~~contractor~~performance bonus expense ~~as a percentage of revenues.~~

~~Table of Contents~~

for our revenue-generating professionals.

Total direct costs for the ~~six~~nine months ended ~~June~~September 30, 2021 included ~~$1.8~~$2.7 million of amortization expense for internal software development costs and intangible assets, compared to ~~$2.6~~$4.0 million of amortization expense for the same prior year period. Intangible asset amortization included within direct costs for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020 related to technology and software, certain customer relationships and customer contracts acquired in connection with our business acquisitions. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information about our intangible assets.

Operating Expenses and Other Losses (Gains), Net

Selling, general and administrative expenses ~~decreased $3.3~~increased $1.6 million, or ~~3.8%~~1.3%, to ~~$85.0~~$128.5 million in the ~~six~~nine months ended ~~June~~September 30, 2021 from ~~$88.3~~$126.9 million in the ~~six~~nine months ended ~~June~~September 30, 2020. The ~~$3.3~~$1.6 million ~~decrease~~increase primarily related to a ~~$4.3~~$1.7 million ~~decrease~~increase in ~~practice administration~~software and ~~meetings expenses,~~data hosting expense, a $2.1 million decrease in promotion and marketing expenses, and a $2.1 million decrease in share-based compensation expense for our support professionals. The decreases in practice administration and meetings expenses and promotion and marketing expenses primarily relate to the cancellation or delay of in-person meetings and events and business travel due to the COVID-19 pandemic. The

decrease in share-based compensation expense primarily related to a decrease in the expected funding of performance-based share awards for our executive officers recorded in the first quarter of 2021. These decreases were partially offset by a $3.7$1.6 million increase in deferred compensation expense, a $1.4 million increase in legal expense, and a $1.1 million increase in signing, retention and other bonus expense for our support personnel. The $1.6 million increase in deferred compensation expense was attributable to the change in the market value of our deferred compensation liability. During the first ~~six~~nine months of 2021, the market value of our deferred compensation liability increased by ~~$2.9~~$2.6 million, compared to ~~a $0.8~~$1.0 million ~~decrease~~ in the first ~~six~~nine months of 2020. This ~~$3.7~~$1.6 million increase in expense is offset by a ~~$3.7~~$1.6 million ~~decrease~~increase in the ~~loss~~gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income (expense), net. ~~Additional~~These increases into selling, general and administrative expenses ~~include~~were largely offset by a ~~$1.4~~$3.7 million ~~increase~~decrease in ~~performance bonus~~practice administration and meetings expense ~~for our support personnel~~ and a ~~$0.9~~$1.0 million ~~increase~~decrease in ~~legal expenses.~~promotion and marketing expense. As a percentage of revenues, selling, general and administrative expenses decreased to ~~19.6% during~~19.5% for the first ~~six~~nine months of 2021 compared to ~~20.0%~~19.6% during the first ~~six~~nine months of ~~2020. This decrease was~~2020, primarily attributable to the ~~decreases~~decrease in practice administration and meetings ~~expenses, promotion and marketing expenses, and share-based compensation~~ expense, ~~for our support personnel, as percentages of revenues, partially~~largely offset by the ~~increase~~increases in ~~deferred compensation expense.~~the other selling, general and administrative expenses described above.

Restructuring charges for the first ~~six~~nine months of 2021 totaled ~~$1.5~~$3.2 million, compared to ~~$1.7~~$1.8 million for the first ~~six~~nine months of 2020. The ~~$1.5~~$3.2 million restructuring charge incurred in the first ~~six~~nine months of 2021 ~~primarily related to~~consisted of $1.8 million of rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office ~~spaces.~~spaces, $0.9 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business within our Business Advisory segment, and $0.5 million of employee-related expenses. The ~~$1.7~~$1.8 million restructuring charge incurred in the first ~~six~~nine months of 2020 primarily related to a $1.2 million accrual for the termination of a third-party advisor agreement; $0.3 million related to workforce reductions to better align resources with market demand; $0.2 million related to rent and related expenses, net of sublease income, for office spaces previously vacated, and $0.1 million related to workforce reductions in our corporate operations. See Note 8 ~~"Restructuring Charges"~~“Restructuring Charges” within the notes to our consolidated financial statements for additional information on our restructuring charges.

Litigation and other ~~gains~~losses (gains), net totaled a net loss of $0.1 million for the nine months ended September 30, 2021, which consisted of remeasurement losses to increase the fair value of our liability for contingent consideration related to a business combination. Litigation and other losses (gains), net totaled a net gain of $0.2 million for the ~~six~~nine months ended ~~June~~September 30, 2020, which consisted of a litigation settlement gain for the resolution of a claim that was settled in the first quarter of 2020.

Depreciation and amortization expense decreased by ~~$1.4~~$2.2 million, or ~~11.6%~~11.9%, to ~~$10.9~~$16.3 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from ~~$12.3~~$18.5 million for the ~~six~~nine months ended ~~June~~September 30, 2020. The ~~$1.4~~$2.2 million decrease was primarily attributable to decreasing amortization expense for customer relationships acquired in business acquisitions due to the accelerated basis of amortization in prior periods, including the customer relationships acquired in our Studer Group acquisition; and customer relationships acquired in other business acquisitions that were fully amortized in prior periods; as well as a decrease in depreciation expense for leasehold improvements and furniture and fixtures related to vacated office spaces. Intangible asset amortization expense included within operating expenses primarily related to certain customer relationships, trade names, and non-competition agreements acquired in connection with our business acquisitions. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on our intangible assets.

During the first quarter of 2020, we recorded $59.8 million of non-cash pretax goodwill impairment charges related to our Strategy and Innovation and Life Sciences reporting units within our Business Advisory segment; primarily related to the expected decline in sales, increased uncertainty in the backlog and a decrease in the demand for the services these reporting units provide, as a result of the COVID-19 pandemic. These charges were non-cash in nature and did not affect our liquidity or debt covenants. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on the charges.

Operating Income (Loss)

Operating income increased ~~$54.3~~$58.9 million to income of ~~$24.4~~$42.7 million in the first ~~six~~nine months of 2021 from a loss of ~~$29.9~~$16.2 million in the first ~~six~~nine months of 2020. This increase is primarily attributable to the $59.8 million of non-cash pretax goodwill impairment charges recognized in the first

Table of Contents

quarter of 2020 related to our Business Advisory segment. Operating margin, which is defined as operating income (loss) expressed as a percentage of revenues, was ~~5.6%~~6.5% for the ~~six~~nine months ended ~~June~~September 30, 2021, compared to ~~(6.8)~~(2.5)% for the ~~six~~nine months ended ~~June~~September 30, 2020. The increase in operating margin was primarily attributable to the goodwill impairment charges recognized in the first quarter of 2020, as well as the ~~decrease~~increase in revenues and decreases in performance bonus expense for our revenue-generating professionals and practice administration and meetings ~~expenses as a percentage of revenues.~~expenses. These increases to the operating margin were partially offset by the ~~increases~~increase in salaries and related expenses for our revenue-generating professionals, ~~and deferred compensation expense.~~

~~Table~~as a percentage of ~~Contents~~

revenues.

Total Other Income (Expense), Net

Interest expense, net of interest income decreased ~~$1.5~~$1.6 million to ~~$3.7~~$6.0 million in the first ~~six~~nine months of 2021 from ~~$5.3~~$7.5 million in the first ~~six~~nine months of 2020, primarily attributable to lower levels of borrowing under our credit facility during the first ~~six~~nine months of 2021 compared to the same prior year period. See Note 7 ~~"Financing Arrangements"~~“Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.

Other income (expense), net increased by ~~$3.9~~$1.5 million to a net gain of ~~$2.6~~$2.2 million in the first ~~six~~nine months of 2021 from a net ~~loss~~gain of ~~$1.3~~$0.7 million in the first ~~six~~nine months of 2020. The increase in total other income, net was primarily attributable to the ~~$2.9~~$2.6 million gain recognized during the first ~~six~~nine months of 2021 for the market value of our investments that are used to fund our deferred compensation liability, compared to ~~a $0.8~~the $1.0 million ~~loss~~gain recognized during the first ~~six~~nine months of 2020.

Income Tax Expense (Benefit)

For the ~~six~~nine months ended ~~June~~September 30, 2021, our effective tax rate was ~~21.5%~~17.9% as we recognized income tax expense from continuing operations of ~~$5.0~~$7.0 million on income from continuing operations of ~~$23.2~~$38.9 million. The effective tax rate of ~~21.5%~~17.9% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6% primarily due to a discrete tax benefit recognized in the third quarter of 2021 related to U.S. federal return to provision adjustments related to the 2020 corporate income tax return. The effective tax rate also reflected the positive impact of certain federal tax credits and a discrete tax benefit recognized during the second quarter of 2021 related to electing the Global Intangible Low-Taxed Income (“GILTI”) high-tax exclusion retroactively for the 2018 tax ~~year and a discrete tax benefit for share-based compensation awards that vested during the first quarter.~~year. On July 20, 2020, the U.S. Treasury issued and enacted final regulations related to GILTI that allow certain U.S. taxpayers to elect to exclude foreign income that is subject to a high effective tax rate from their GILTI inclusions. The GILTI high-tax exclusion is an annual election and is retroactively available. These favorable items were partially offset by certain nondeductible ~~expense items.~~business expenses.

For the ~~six~~nine months ended ~~June~~September 30, 2020, our effective tax rate was ~~21.4%~~23.5% as we recognized an income tax benefit from continuing operations of ~~$7.8~~$5.4 million on a loss from continuing operations of ~~$36.5~~$23.0 million. The effective tax rate of ~~21.4%~~23.5% was less favorable than the statutory rate, inclusive

of state income taxes, of 26.0%, primarily due to certain nondeductible business expenses and the nondeductible portion of the goodwill impairment

charges recorded during the first quarter of 2020. These unfavorable items were partially offset by a discrete tax benefit for share-based

compensation awards that vested during the first quarter, the positive impact of certain federal tax credits, and a discrete tax benefit for the remeasurement portion of our income tax receivable as

a result of the enactment of the CARES Act in the first quarter of 2020.

The CARES Act, which was signed into law on March 27, 2020, is an approximately $2 trillion emergency economic stimulus package in response to the COVID-19 outbreak, which among other items, includes income tax provisions relating to net operating loss carryback periods and technical corrections to tax depreciation methods for qualified improvement property. ~~During~~In the first nine months of 2020, as a result of the CARES Act, we recognized a $0.8 million tax benefit related to the remeasurement of a portion of our income tax receivable ~~for~~due to the ability to apply the federal net operating loss incurred in 2018 ~~and the expected federal net operating loss in 2020 that will be carried back~~ to prior year income ~~both~~ for a refund at the higher ~~prior year~~ tax ~~rate.~~rate in the carryback period. As a result of electing the retroactive GILTI high-tax exclusion ~~during~~in the second quarter of 2021, we recognized a $1.0 million tax benefit of which $0.4 million related to carrying back our increased 2018 federal net operating loss to prior year income for a refund at the higher, prior year tax rate. During the third quarter of 2021, we recognized an additional tax benefit of $2.0 million primarily related to the U.S. federal return to provision adjustments for carrying back our increased 2020 federal net operating loss to prior year income for a refund at the higher, prior year tax rate.

See Note 12 ~~"Income Taxes"~~“Income Taxes” within the notes to our consolidated financial statements for additional information on our income tax expense.

Net Income (Loss) from Continuing Operations and Earnings (Loss) Per Share

Net income from continuing operations increased by ~~$46.9~~$49.5 million to net income from continuing operations of ~~$18.2~~$31.9 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from a net loss from continuing operations of ~~$28.7~~$17.6 million for the same prior year period. This increase is primarily attributable to the $59.8 million of non-cash pretax goodwill impairment charges recognized in the first quarter of 2020 related to our Business Advisory segment. As a result of the increase in net income from continuing operations, diluted earnings per share from continuing operations for the first ~~six~~nine months of 2021 was ~~$0.82~~$1.46 compared to a loss per share from continuing operations of ~~$1.31~~$0.81 for the first ~~six~~nine months of 2020. The non-cash goodwill impairment charges had a ~~$2.14~~$2.11 unfavorable impact on diluted earnings per share from continuing operations for the first ~~six~~nine months of 2020.

Table of Contents

EBITDA and Adjusted EBITDA

EBITDA increased ~~$56.3~~$57.5 million to ~~earnings of $40.0~~$64.5 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from ~~a loss of $16.3~~$7.0 million for the ~~six~~nine months ended ~~June~~September 30, 2020. The increase in EBITDA was primarily attributable to the non-cash goodwill impairment charges of $59.8 million recognized in the first quarter of 2020. Adjusted EBITDA decreased ~~$4.4~~$1.6 million to ~~$42.1~~$68.5 million in the first ~~six~~nine months of 2021 from ~~$46.5~~$70.1 million in the first ~~six~~nine months of 2020. The decrease in adjusted EBITDA was primarily attributable to an increase in corporate expenses, excluding the change in the market value of our deferred compensation liability for the first nine months of 2021 compared to the first nine months of 2020 and restructuring charges not allocated at the segment level, partially offset by the overall ~~decrease~~increase in segment operating income, ~~discussed below in Segment Results,~~ excluding depreciation and amortization and restructuring charges allocated at the segment level. See Segment Results below for additional information on segment operating income.

Adjusted Net Income from Continuing Operations and Adjusted Earnings per Share

Adjusted net income from continuing operations ~~decreased $1.8~~increased $1.9 million to ~~$22.9~~$39.7 million in the first ~~six~~nine months of 2021 compared to ~~$24.7~~$37.7 million in the first ~~six~~nine months of 2020. As a result of the ~~decrease~~increase in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations for the first ~~six~~nine months of 2021 was ~~$1.03~~$1.81 compared to ~~$1.11~~$1.70 for the first ~~six~~nine months of 2020.

~~Table of Contents~~

Segment Results

Healthcare

Revenues

Healthcare segment revenues increased ~~$0.1~~$5.6 million, or 2.1%, to ~~$181.1~~$273.9 million for the first ~~six~~nine months of 2021 from ~~$180.9~~$268.3 million for the first ~~six~~nine months of 2020. The overall increase was primarily due to strengthened demand for this segment's services in the second ~~quarter~~and third quarters of 2021 ~~largely offset~~and the favorable comparison against the first nine months of 2020, which was more significantly impacted by ~~the negative impact of~~ the COVID-19 pandemic ~~on demand for this segment's services through~~as some clients reprioritized and delayed certain projects as a result of the ~~first quarter of 2021.~~uncertainties surrounding the pandemic.

During the ~~six~~nine months ended ~~June~~September 30, 2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~57.1%~~58.5%, ~~16.2%~~17.2%, ~~20.9%~~18.4%, and ~~5.8%~~5.9% of this segment’s revenues, respectively, compared to 58.9%, ~~15.9%~~16.2%, ~~18.5%~~18.3%, and ~~6.7%~~6.6% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was ~~$37.7~~$50.4 million during the first ~~six~~nine months of 2021, compared to ~~$33.4~~$49.0 million during the first ~~six~~nine months of 2020. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

Of the overall ~~$0.1~~$5.6 million increase in revenues, ~~$6.7~~$13.9 million was attributable to an increase in revenues from our Healthcare Managed Services employees and ~~$1.4~~$0.9 million was attributable to an increase in revenues from our billable consultants, ~~largely~~partially offset by ~~an $8.0~~a $9.2 million decrease in revenues from our full-time equivalents.

The increase in revenues attributable to our Healthcare Managed Services employees was primarily attributable to an increase in demand for these services, which led to an increase in the average number of managed services employees in the first ~~half~~nine months of 2021 compared to the same prior year ~~period driven by the hiring of approximately 300 employees in~~period. At the beginning of the second quarter of 2021, we hired approximately 300 employees to expand our capacity to manage and provide revenue cycle billing, collections, insurance verification and change integrity services to our healthcare clients. These employees are serving new and existing clients in our Healthcare Managed Services solution, including serving under a short-term contract with an existing client which we entered into in connection with this group hire.

The increase in revenues attributable to our billable consultants reflected ~~a decrease in the average number of billable consultants, partially offset by~~ increases in the average billing rate and the consultant utilization rate, largely offset by a decrease in the average number of billable consultants during the first ~~six~~nine months of 2021 compared to the same prior year period.

The decrease in full-time equivalent revenues was primarily driven by a decrease in demand for certain services and a decreased use of contractors and project consultants; and reflected ~~decreases~~a decrease in the average number of full-time equivalents, ~~and~~partially offset by an increase in revenue per full-time equivalent in the first ~~six~~nine months of 2021 compared to the same prior year period.

Operating Income

Healthcare segment operating income increased ~~$2.9~~$7.5 million, or ~~6.4%~~10.6%, to ~~$48.1~~$78.4 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from ~~$45.2~~$70.8 million for the ~~six~~nine months ended ~~June~~September 30, 2020. The Healthcare segment operating margin increased to ~~26.6%~~28.6% for the first ~~six~~nine months of 2021 from ~~25.0%~~26.4% in the same period last year. The increase in this segment’s operating margin was primarily attributable to decreases in practice administration and meetings ~~expenses,~~expense, contractor ~~expenses,~~expense, and salaries and related expenses for our support ~~personnel, salaries and related expenses for our revenue-generating professionals, share-based compensation expense for our revenue-generating professionals, and product and event costs.~~personnel. These increases to the segment operating margin were partially offset by ~~increases~~an increase in ~~performance bonus expense for our revenue-generating professionals and~~ signing, retention and other bonus expense for our revenue-generating professionals, ~~both~~ as ~~percentages~~a percentage of revenues.

Table of Contents

Business Advisory

Revenues

Business Advisory segment revenues increased ~~$8.4~~$12.3 million, or ~~6.2%~~6.1%, to ~~$143.8~~$213.7 million for the first ~~six~~nine months of 2021 from ~~$135.4~~$201.4 million for the first ~~six~~nine months of 2020, primarily related to strengthened demand for our cloud-based technology and analytics solutions and our strategy and innovation solutions. Revenues for the first ~~six~~nine months of 2021 included ~~$7.3~~$11.9 million from our acquisitions of ForceIQ and Unico Solutions, which were completed in November 2020 and February 2021, respectively.

During the first ~~six~~nine months of 2021, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~42.6%~~43.0%, ~~51.2%~~50.9%, ~~3.4%~~3.1%, and ~~2.8%~~3.0% of this segment’s revenues, respectively, compared to ~~39.0%~~36.5%, ~~57.5%~~58.8%, ~~1.6%~~2.9%, and ~~1.9%~~1.8% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was ~~$4.9~~$6.5 million for the first ~~six~~nine months of 2021, compared to ~~$2.2~~$5.9 million for the first ~~six~~nine months of 2020. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.

Of the overall ~~$8.4~~$12.3 million increase in revenues, ~~$6.7~~$8.8 million was attributable to revenues generated by our billable consultants and ~~$1.7~~$3.5 million was attributable to our full-time equivalents. The increase in revenues from our billable consultants was primarily driven by an increase in the average number of billable consultants, partially offset by decreases in the consultant utilization rate and the average billing rate in the first ~~six~~nine months of 2021 compared to the same prior year period. The increase in revenues from our full-time equivalents was driven by an increased use of contractors and project consultants; and reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the first ~~six~~nine months of 2021 compared to the same prior year period.

~~Table~~On November 1, 2021, we completed the divestiture of ~~Contents~~

the Life Sciences business to Oliver Wyman. The Life Sciences business, a reporting unit within the Business Advisory segment, provides commercial and research and development strategy, pricing and market access strategy solutions to customers in the life sciences industries. For the nine months ended September 30, 2021, Life Sciences revenues were $14.8 million. The Life Sciences business is not significant to our consolidated financial statements and does not qualify as a discontinued operation for reporting under GAAP.

Operating Income

Business Advisory segment operating income ~~increased by $0.9 million, or 3.3%, to $27.4~~was $37.3 million for both the ~~six~~nine months ended ~~June~~September 30, 2021 ~~from $26.5 million for the six months ended June 30,~~and 2020. The Business Advisory segment operating margin decreased to ~~19.1%~~17.4% for the first ~~six~~nine months of 2021 from ~~19.6%~~18.5% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries and related expenses for our revenue-generating professionals, contractor expense, and salaries and related expenses for our support personnel, as percentages of revenues; ~~largely~~partially offset by decreases in performance bonus expense for our revenue-generating professionals and restructuring ~~charges, promotion and marketing expenses, bad debt expense, and signing, retention and other bonus expense for our revenue-generating professionals.~~charges.

The first quarter 2020 non-cash goodwill impairment charges related to the Strategy and Innovation and Life Sciences reporting units within the Business Advisory segment, which are discussed above within consolidated results, are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segment. We do not include the impact of goodwill impairment charges in our evaluation of segment performance. See Note 4 ~~"Goodwill~~“Goodwill and Intangible ~~Assets"~~Assets” within the notes to our consolidated financial statements for additional information on the goodwill impairment charges recorded in the first quarter of 2020 and our goodwill balances.

Education

Revenues

Education segment revenues decreased ~~$15.7~~$6.3 million, or ~~12.6%~~3.6%, to ~~$108.5~~$169.7 million for the first ~~six~~nine months of 2021 from ~~$124.2 million.~~$176.0 million for the first nine months of 2020. The decrease in revenues was primarily related to the negative impact of the COVID-19 pandemic on demand for this segment's services beginning in the ~~second half~~third quarter of 2020 and continuing through the second quarter of 2021 as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the ~~pandemic, and~~pandemic. The decrease in revenues is also reflective of the difficult ~~first half~~prior year comparison driven by the strong growth ~~we experienced in~~of this ~~segment~~segment's revenues in the first half of 2020 prior to the impact of the pandemic on this segment.

For the ~~six~~nine months ended ~~June~~September 30, 2021, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented ~~30.5%~~28.4%, ~~57.0%~~59.3%, and ~~12.5%~~12.3% of this segment's revenues, respectively. During the same prior year period, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented ~~19.8%~~20.2%, ~~71.1%~~70.1%, ~~0.6%~~0.4% and ~~8.5%~~9.3% of this segment’s revenues, respectively.

Of the overall ~~$15.7~~$6.3 million decrease in revenues, ~~$14.8~~$7.8 million was attributable to a decrease in revenues generated by our ~~full-time~~ billable consultants, ~~and $0.9~~partially offset by a $1.5 million ~~was attributable to a decrease~~increase in revenues generated by our full-time equivalents. The decrease in revenues from our full-time billable consultants reflected decreases in the average number of billable consultants and the average billing rate, ~~and~~partially offset by an increase in the consultant utilization rate in the first ~~six~~nine months of 2021 compared to the same prior year period. The ~~decrease~~increase in revenues from our full-time equivalents was primarily driven ~~by a decreased use of contractors and project consultants, partially offset~~ by an increase in software subscriptions, software support and maintenance, and data hosting ~~revenues.~~revenues, partially

Table of Contents

offset by a decreased use of contractors and project consultants. The overall ~~decrease~~increase in full-time equivalent revenues reflected an increase in revenue per full-time equivalent, partially offset by a decrease in the average number of full-time equivalents ~~partially offset by an increase in revenue per full-time equivalent~~ in the first ~~six~~nine months of 2021 compared to the same prior year period.

Operating Income

Education segment operating income decreased ~~$6.8~~$4.6 million, or ~~23.3%~~11.0%, to ~~$22.4~~$37.2 million for the ~~six~~nine months ended ~~June~~September 30, 2021, from ~~$29.2~~$41.8 million for the ~~six~~nine months ended ~~June~~September 30, 2020. The Education segment operating margin decreased to ~~20.7%~~21.9% for the first ~~six~~nine months of 2021 from ~~23.6%~~23.7% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to ~~increases~~an increase in performance bonus expense for our revenue-generating professionals and an increase in salaries and related expenses for our revenue-generating professionals as a percentage of ~~revenues and an increase in technology expenses,~~revenues. These increases to the segment's operating margin were partially offset by ~~decreases~~a decrease in contractor expense, ~~and promotion and marketing expenses,~~ as ~~percentages~~a percentage of revenues.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents decreased ~~$54.2~~$56.0 million to ~~$13.0~~$11.2 million at ~~June~~September 30, 2021 from $67.2 million at December 31, 2020. As of ~~June~~September 30, 2021, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.

Six Months Ended
June 30,
Cash Flows (in thousands): 2021 2020
Net cash provided by (used in) operating activities $ (61,970) $ 1,805
Net cash used in investing activities (13,752) (24,141)
Net cash provided by financing activities 21,258 94,051
Effect of exchange rate changes on cash 269 (107)
Net increase (decrease) in cash and cash equivalents $ (54,195) $ 71,608

~~Table of Contents~~


	Nine Months Ended September 30,
Cash Flows (in thousands):	2021		2020
Net cash provided by (used in) operating activities	$	(28,206)	$	77,985
Net cash used in investing activities	(18,726)		(28,388)
Net cash provided by (used in) financing activities	(9,245)		13,517
Effect of exchange rate changes on cash	189		27
Net increase (decrease) in cash and cash equivalents	$	(55,988)	$	63,141

Operating Activities

Net cash used in operating activities totaled ~~$62.0~~$28.2 million for the ~~six~~nine months ended ~~June~~September 30, 2021, compared to net cash provided by operating activities of ~~$1.8~~$78.0 million for the ~~six~~nine months ended ~~June~~September 30, 2020. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances.

The ~~increase~~decrease in net operating cash ~~used in operating activities~~flows for the first ~~six~~nine months of 2021 compared to the same prior year period was primarily attributable to a decrease in cash collections in the first nine months of 2021 compared to the same prior year period and the $12.2 million payment in the third quarter of 2021 of the employer's portion of social security taxes deferred under the CARES Act. These decreases to net operating cash flows were partially offset by a decrease in the amount paid for annual performance bonuses in the first quarter of 2021 compared to the first quarter of ~~2020 and a decrease in selling, general and administrative expenses during the first six months of 2021 compared to the first six months of~~ 2020.

Investing Activities

Net cash used in investing activities was ~~$13.8~~$18.7 million and ~~$24.1~~$28.4 million for the ~~six~~nine months ended ~~June~~September 30, 2021 and 2020, respectively.

The use of cash in the first ~~six~~nine months of 2021 primarily consisted of ~~$5.9 million for the purchase of a business; $5.4~~$8.9 million for purchases of property and equipment, primarily related to purchases of leasehold improvements and furniture for certain office spaces and computers and related equipment; $5.9 million for the purchase of a business; and ~~$2.5~~$3.6 million for payments related to internally developed software.

The use of cash in the first ~~six~~nine months of 2020 primarily consisted of $13.0 million for the purchase of an additional convertible debt investment in

Shorelight Holdings, LLC; ~~$5.2~~$6.8 million for payments related to internally developed software; ~~$4.4~~$5.7 million for purchases of property and equipment, primarily related to purchases of ~~furniture~~leasehold improvements and ~~leasehold improvements~~furniture for certain office spaces and computers and related equipment; and ~~$1.5~~$2.0 million for contributions to our life insurance policies which fund our deferred compensation plan.

We estimate that cash utilized for purchases of property and equipment and software development in 2021 will total approximately $13 million to $17 million; primarily consisting of leasehold improvements for certain office locations, software development costs, and information technology equipment.

Table of Contents

Financing Activities

Net cash ~~provided by~~used in financing activities was ~~$21.3 million and $94.1~~$9.2 million for the ~~six~~nine months ended ~~June~~September 30, ~~2021 and June 30, 2020, respectively.~~

2021. During the first ~~six~~nine months of 2021, we borrowed ~~$139.0~~$189.0 million under our credit facility, primarily to fund our operations, including our annual performance bonus payment in the first quarter of 2021, and made repayments on our borrowings of ~~$74.3~~$129.4 million. Additionally, during the first ~~six~~nine months of 2021, we repurchased and retired ~~$35.2~~$60.2 million of our common stock under our 2020 Share Repurchase Program, as defined below.

Net cash provided by financing activities was $13.5 million for the nine months ended September 30, 2020. During the first ~~six~~nine months of 2020, we borrowed $283.0 million under our credit facility, including $125.0 million prior to March 31, 2020 to maintain excess cash and support liquidity during the period of uncertainty created by the COVID-19 pandemic, as well as to fund our annual performance bonus payment. During the first ~~six~~nine months of 2020, we made repayments on our borrowings of ~~$160.3~~$240.4 million, including ~~a $120.0~~$200.0 million ~~payment~~ in the second ~~quarter of 2020 to repay a portion of the additional borrowings made in the first quarter~~and third quarters of 2020 due to our ability to maintain adequate cash flows from operations and improved clarity around access to capital resources. Additionally, we repurchased and retired $20.9 million of our common stock under our 2015 Share Repurchase Program, as defined below, and settled $1.2 million of share repurchases that were accrued as of December 31, 2019.

Share Repurchase Program

In November 2020, our board of directors authorized a share repurchase program (the “2020 Share Repurchase Program”) permitting us to

repurchase up to $50 million of our common stock through December 31, 2021. The 2020 Share Repurchase Program was authorized subsequent to the expiration of our prior share repurchase program (the “2015 Share Repurchase Program”) on October 31, 2020. The 2015 Share Repurchase Program permitted us to repurchase up to $125 million of our common stock through October 31, 2020. ~~The 2020 Share Repurchase Program and 2015 Share Repurchase Program are collectively known as the “Share Repurchase Programs.”~~

Under the 2020 Share Repurchase Program, we repurchased and retired 651,081 shares for $35.2 million, during the six months ended June 30, 2021. Under the 2015 Share Repurchase Program, we repurchased and retired 313,998 shares for $20.9 million, during the six months ended June 30, 2020. Additionally, in the first quarter of 2020, we settled the repurchase of 18,000 shares for $1.2 million that were accrued as of December 31, 2019. As of June 30, 2021, $9.7 million remained available for share repurchases under the 2020 Share Repurchase Program.

During the third quarter of 2021, our board of directors authorized an extension of the 2020 Share Repurchase Program through December 31, 2022 and increased the authorized amount from $50 million to $100 million. The amount and timing of repurchases under ~~the Share Repurchase~~

~~Table of Contents~~

~~Programs~~both share repurchase programs were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.

In the three and nine months ended September 30, 2021, we repurchased and retired 518,045 and 1,169,126 shares for $25.0 million and $60.2 million, respectively, under the 2020 Share Repurchase Program. In the first quarter of 2020, we repurchased 313,998 shares for $20.9 million under the 2015 Share Repurchase Program. Additionally, in the first quarter of 2020, we settled the repurchase of 18,000 shares for $1.2 million that were accrued as of December 31, 2019. No shares were repurchased in the second or third quarters of 2020. As of September 30, 2021, $34.7 million remained available for share repurchases under the 2020 Share Repurchase Program.

Financing Arrangements

At ~~June~~September 30, 2021, we had ~~$265.0~~$260.0 million outstanding under our senior secured credit facility and ~~$3.1~~$2.9 million outstanding under a promissory note, as discussed below.

Senior Secured Credit Facility

The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. Borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

Table of Contents

on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At ~~June~~September 30, 2021 and December 31, 2020, we were in compliance with these financial covenants. Our Consolidated Leverage Ratio as of ~~June~~September 30, 2021 was ~~2.80~~2.73 to 1.00, compared to 1.94 to 1.00 as of December 31, 2020. Our Consolidated Interest Coverage Ratio as of ~~June~~September 30, 2021 was ~~13.83~~13.99 to 1.00, compared to 12.51 to 1.00 as of December 31, 2020.

The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.25, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $25 million.

Principal borrowings outstanding under the Amended Credit Agreement at ~~June~~September 30, 2021 and December 31, 2020 totaled ~~$265.0~~$260.0 million and $200.0 million, respectively. These borrowings carried a weighted average interest rate of ~~2.4%~~2.7% at ~~June~~September 30, 2021 and 2.5% at December 31, 2020, including the impact of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At ~~June~~September 30, 2021, we had outstanding letters of credit totaling $0.7 million, which are primarily used as security deposits for our office facilities. As of ~~June~~September 30, 2021, the unused borrowing capacity under the revolving credit facility was ~~$334.3~~$339.3 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At ~~June~~September 30, 2021, the outstanding principal amount of the promissory note was ~~$3.1~~$2.9 million, and the aircraft had a carrying amount of ~~$4.1~~$3.9 million. At December 31, 2020, the outstanding principal amount of the promissory note was $3.3 million, and the aircraft had a carrying amount of $4.4 million.

~~Table of Contents~~

For further information, see Note 7 “Financing Arrangements” within the notes to the consolidated financial statements.

Future Financing Needs

~~Our current~~Throughout 2020 and into 2021, our primary financing need iswas to support our operations and maintain our liquidity during the COVID-19 pandemic. The pandemic has created significant volatility and uncertainty in the economy, which could limit our access to capital resources and could increase our borrowing costs. In order to support our liquidity during the pandemic,As such, we took proactive measures to increase available cash on hand, including, but not limited to, borrowing under our senior secured credit facility, ~~in the first quarter of 2020 and~~ reducing discretionary operating and capital ~~expenses. To further support our liquidity, we elected~~expenses, and electing to defer the deposit of our employer portion of social security taxes ~~beginning in April 2020 and through December 2020,~~ as provided for under the CARES Act. ~~These deferred payments are due in equal installments in the fourth quarters of 2021~~

Given improved visibility to our project backlog and ~~2022. Our long-term~~access to capital resources, our primary financing need has ~~been~~now returned to ~~fund~~funding our long-term growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures. We believe our internally generated liquidity, together with our available cash, and the borrowing capacity available under our revolving credit facility will be adequate to support our current financing needs and long-term growth strategy. Our ability to secure additional financing, if needed, in the future will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

CONTRACTUAL OBLIGATIONS

For a summary of our commitments to make future payments under contractual obligations, see Item 7. ~~"Management’s~~“Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual ~~Obligations"~~Obligations” in our Annual Report on Form 10-K for the year ended December 31, 2020. As of ~~June~~September 30, 2021, borrowings outstanding under our senior secured credit facility totaled ~~$265.0~~$260.0 million compared to $200.0 million at December 31, 2020. See the ~~"Liquidity~~“Liquidity and Capital ~~Resources"~~Resources” section above and Note 7 ~~"Financing Arrangements"~~“Financing Arrangements” within the notes to our consolidated financial statements for additional information on our outstanding borrowings as of ~~June~~September 30, 2021. There have been no other material changes to our contractual obligations since December 31, 2020.

OFF-BALANCE SHEET ARRANGEMENTS

We are not a party to any material off-balance sheet arrangements.

Table of Contents

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ~~("GAAP"~~(“GAAP”). We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see Item 7. ~~"Management’s~~“Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting ~~Policies"~~Policies” in our Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to our critical accounting policies during the first ~~six~~nine months of 2021.

NEW ACCOUNTING PRONOUNCEMENTS

~~Refer to~~See Note 3 ~~"New~~“New Accounting ~~Pronouncements"~~Pronouncements” within the notes to the consolidated financial statements for information on new accounting pronouncements.

SUBSEQUENT EVENTS

On November 1, 2021, we completed the divestiture of our Life Sciences business to Oliver Wyman. The Life Sciences business, a reporting unit within the Business Advisory segment, provides commercial and research and development strategy, pricing and market access strategy solutions to customers in the life sciences industries. For the three and nine months ended September 30, 2021, Life Sciences revenues were $5.1 million and $14.8 million, respectively. The Life Sciences business is not significant to our consolidated financial statements and does not qualify as a discontinued operation for reporting under GAAP.


ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.

Market Risk and Interest Rate Risk

We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which has variable interest rates tied to LIBOR or an alternate base rate, at our option. At ~~June~~September 30, 2021, we had borrowings outstanding under the credit facility totaling ~~$265.0~~$260.0 million that carried a weighted average interest rate of ~~2.4%~~2.7%, including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have a ~~$0.7~~$0.6 million effect on our pretax income on an annualized basis, including the effect of the interest rate

~~Table of Contents~~

swaps. At December 31, 2020, we had borrowings outstanding under the credit facility totaling $200.0 million that carried a weighted average interest rate of 2.5% including the impact of the interest rate swaps. As of December 31, 2020, these variable rate borrowings were fully hedged against changes in interest rates by the interest rate swaps, which have a notional amount of $200.0 million. A hypothetical 100 basis point change in the interest rate would have had no impact on our pretax income, on an annualized basis, including the effect of the interest rate swaps.

On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.

We also have exposure to changes in interest rates associated with the promissory note assumed on June 30, 2017 in connection with our purchase of an aircraft, which has variable interest rates tied to LIBOR. At ~~June~~September 30, 2021, the outstanding principal amount of the promissory note was ~~$3.1~~$2.9 million and carried an interest rate of 2.1%. A hypothetical 100 basis point change in this interest rate would not have a material effect on our

Table of Contents

pretax income. At December 31, 2020, the outstanding principal amount of the promissory note was $3.3 million and carried an interest rate of 2.1%. A hypothetical 100 basis point change in the interest rate as of December 31, 2020 would not have had a material effect on our pretax income.

We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure.

We have an investment in the form of 1.69% convertible debt in Shorelight Holdings, LLC, a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of ~~June~~September 30, 2021, the fair value of the investment was ~~$60.0~~$61.5 million, with a total cost basis of $40.9 million. At December 31, 2020, the fair value of the investment was $64.4 million, with a total cost basis of $40.9 million.

We have a preferred stock investment in Medically Home Group, Inc., a privately-held company, which we account for as an equity security without a readily determinable fair value using the measurement alternative. As such, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment. Any unrealized holding gains and losses resulting from observable price changes are recorded in our consolidated statement of operations. As of ~~June~~September 30, 2021 and December 31, 2020, the carrying value of the investment was $6.7 million, with a total cost basis of $5.0 million. Following our purchase, we have not identified any impairment of our investment.

See Note 10 “Fair Value of Financial Instruments” for further information on our long-term investments in Shorelight Holdings, LLC and Medically Home Group, Inc.


ITEM 4.			CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the

effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities

Exchange Act of 1934, as amended (the ~~"Exchange Act"~~“Exchange Act”)) as of ~~June~~September 30, 2021. Based on this evaluation, our Chief Executive Officer

and Chief Financial Officer have concluded that, as of ~~June~~September 30, 2021, our disclosure controls and procedures were effective in

recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or

submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely

decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the

Exchange Act) during the three months ended ~~June~~September 30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal

control over financial reporting.

~~Table of Contents~~

PART II—OTHER INFORMATION


ITEM 1.			LEGAL PROCEEDINGS.

The information required by this Item is incorporated by reference from Note 13 ~~"Commitments,~~“Commitments, Contingencies and ~~Guarantees"~~Guarantees” included in Part I, Item 1 of this Form 10-Q.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.


ITEM 1A.			RISK FACTORS.

See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 23, 2021, for a complete description of the material risks we face.

Table of Contents


ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Our Stock Ownership Participation Program, 2012 Omnibus Incentive Plan, and 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended ~~June~~September 30, 2021, we reacquired ~~2,843~~12,489 shares of common stock with a weighted average fair market value of ~~$52.09~~$49.35 as a result of such tax withholdings.

AsIn November 2020, our board of ~~June 30, 2021, we have~~directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021 (the ~~"2020~~“2020 Share Repurchase ~~Program"~~Program”). During the third quarter of 2021, our board of directors authorized an extension of the 2020 Share Repurchase Program through December 31, 2022 and increased the authorized amount from $50 million to $100 million. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our line of credit, general market and business conditions, and applicable legal requirements.

The following table provides information with respect to purchases we made of our common stock during the quarter ended ~~June~~September 30, 2021.

Period
Total Number of Shares Purchased (1)
Average Price
Paid per Share Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
April 1, 2021 - April 30, 2021 367,116 $ 54.11 365,994 $ 11,972,407
May 1, 2021 - May 31, 2021 39,369 $ 56.89 39,369 $ 9,731,354
June 1, 2021 - June 30, 2021 1,721 $ 53.21 — $ 9,731,354
Total 408,206 $ 54.37 405,363


Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
July 1, 2021 - July 31, 2021	2,739	$	49.15	—	$	59,731,354
August 1, 2021 - August 31, 2021	526,471	$	48.22	518,045	$	34,745,565
September 1, 2021 - September 30, 2021	1,324	$	49.10	—	$	34,745,565
Total	530,534	$	48.23	518,045

(1)The number of shares repurchased included ~~1,122~~2,739 shares in ~~April~~July 2021, 8,426 shares in August 2021, and ~~1,721~~1,324 shares in ~~June~~September 2021 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the 2020 Share Repurchase Program.

(2)As of the end of the period.


ITEM 3.			DEFAULTS UPON SENIOR SECURITIES.

None.


ITEM 4.			MINE SAFETY DISCLOSURES.

Not applicable.


ITEM 5.			OTHER INFORMATION.

None.

Table of Contents


ITEM 6.			EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed
herewith

Furnished
herewith

Form

Period
Ending

Exhibit

Filing
Date

10.1

~~Amendment to~~Form of the Huron Consulting Group Inc. ~~Amended and Restated~~ 2012 Omnibus Incentive Plan ~~effective May 7, 2021.~~Restricted Stock Unit Agreement.

~~DEF 14A~~

~~Appendix A~~

~~3/26/2021~~

31.1

Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Huron Consulting Group Inc.

(Registrant)

Date:

~~July 29,~~November 2, 2021

/S/ JOHN D. KELLY

John D. Kelly

Executive Vice President,
Chief Financial Officer and Treasurer


		Page
Part I – Financial Information

Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations and Other Comprehensive Income	2
	Consolidated Statements of Stockholders’ Equity	3
	Consolidated Statements of Cash Flows	4
	Notes to Consolidated Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2423

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	43

Item 4.	Controls and Procedures	44

Part II – Other Information

Item 1.	Legal Proceedings	4544

Item 1A.	Risk Factors	4544

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45

Item 3.	Defaults Upon Senior Securities	45

Item 4.	Mine Safety Disclosures	45

Item 5.	Other Information	45

Item 6.	Exhibits	46

Signature		47


	As of June 30,
	2021	2020
Unvested restricted stock awards	27	58


Total anti-dilutive securities	27	58


	Three Months Ended June 30, 2021						Three Months Ended June 30, 2020
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	82	$	0	$	82	$	104	$	0	$	104
Unrealized gain (loss) on investment	$	1,936	$	(514)	$	1,422	$	(7,670)	$	1,992	$	(5,678)
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	(305)	$	78	$	(227)	$	(2,640)	$	686	$	(1,954)
Reclassification adjustments into earnings	601		(156)		445		337		(88)		249
Net unrealized gain (loss)	$	296	$	(78)	$	218	$	(2,303)	$	598	$	(1,705)
Other comprehensive income (loss)	$	2,314	$	(592)	$	1,722	$	(9,869)	$	2,590	$	(7,279)